Luminar (LAZR) 10-Q8 Nov 232023 Q3 Quarterly reportFinancial data

Company Profile

Cover Page

Cover Page - shares	9 Months Ended
Cover Page - shares	Sep. 30, 2023	Oct. 31, 2023
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2023
Document Transition Report	false
Entity File Number	001-38791
Entity Registrant Name	Luminar Technologies, Inc./DE
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	83-1804317
Entity Address, Address Line One	2603 Discovery Drive
Entity Address, Address Line Two	Suite 100
Entity Address, City or Town	Orlando
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	32826
City Area Code	800
Local Phone Number	532-2417
Title of 12(b) Security	Class A common stock, par value of $0.0001 per share
Trading Symbol	LAZR
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001758057
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Class A Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		304,866,400
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		97,088,670

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 74,723	$ 69,552
Restricted cash	3,465	1,553
Marketable securities	246,242	419,314
Accounts receivable	18,903	11,172
Inventory	16,698	8,792
Prepaid expenses and other current assets	29,389	44,203
Total current assets	389,420	554,586
Property and equipment, net	72,647	30,260
Operating lease right-of-use assets	19,660	21,244
Intangible assets, net	27,059	22,077
Goodwill	19,879	18,816
Other non-current assets	24,213	40,344
Total assets	552,878	687,327
Current liabilities:
Accounts payable	20,732	18,626
Accrued and other current liabilities	58,489	52,962
Operating lease liabilities	6,475	5,953
Total current liabilities	85,696	77,541
Warrant liabilities	1,660	3,005
Convertible senior notes	614,619	612,192
Operating lease liabilities, non-current	15,551	16,989
Other non-current liabilities	1,017	4,005
Total liabilities	718,543	713,732
Commitments and contingencies (Note 14)
Stockholders’ deficit:
Additional paid-in capital	1,838,299	1,558,685
Accumulated other comprehensive loss	(235)	(4,226)
Treasury stock	(312,477)	(312,477)
Accumulated deficit	(1,691,294)	(1,268,426)
Total stockholders’ deficit	(165,665)	(26,405)
Total liabilities and stockholders’ deficit	552,878	687,327
Class A common stock
Stockholders’ deficit:
Common stock	32	29
Class B common stock
Stockholders’ deficit:
Common stock	$ 10	$ 10

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Total revenue	$ 16,959	$ 12,785	$ 47,665	$ 29,572
Total cost of sales	35,119	28,511	98,784	73,257
Gross loss	(18,160)	(15,726)	(51,119)	(43,685)
Operating expenses:
Research and development	62,937	46,308	199,472	120,358
Sales and marketing	12,397	10,111	41,780	26,698
General and administrative	35,435	42,809	122,345	110,984
Total operating expenses	110,769	99,228	363,597	258,040
Loss from operations	(128,929)	(114,954)	(414,716)	(301,725)
Change in fair value of warrant liabilities	2,373	(1,231)	1,345	6,645
Interest expense	(2,779)	(2,660)	(5,717)	(9,088)
Interest income	1,260	1,553	4,770	3,970
Other income (expense)	(5,967)	(83)	(8,245)	(358)
Total other income (expense), net	(5,113)	(2,421)	(7,847)	1,169
Loss before provision for income taxes	(134,042)	(117,375)	(422,563)	(300,556)
Provision for income taxes	296	175	305	566
Net loss	$ (134,338)	$ (117,550)	$ (422,868)	$ (301,122)
Net loss per share:
Basic (in dollars per share)	$ (0.34)	$ (0.33)	$ (1.11)	$ (0.85)
Diluted (in dollars per share)	$ (0.34)	$ (0.33)	$ (1.11)	$ (0.85)
Shares used in computing net loss per share:
Basic (in shares)	394,591,942	359,753,254	382,673,871	353,537,754
Diluted (in shares)	394,591,942	359,753,254	382,673,871	353,537,754
Comprehensive Loss:
Net loss	$ (134,338)	$ (117,550)	$ (422,868)	$ (301,122)
Net unrealized gain (loss) on available-for-sale debt securities	573	16	3,991	(5,081)
Comprehensive loss	(133,765)	(117,534)	(418,877)	(306,203)
Products
Total revenue	10,753	6,796	28,043	10,135
Total cost of sales	27,273	18,364	71,535	47,169
Services
Total revenue	6,206	5,989	19,622	19,437
Total cost of sales	$ 7,846	$ 10,147	$ 27,249	$ 26,088

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($) $ in Thousands	Total	Freedom Photonics LLC	Solfice Research, Inc.	TPK Universal Solutions Limited	Equity Financing Program	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Freedom Photonics LLC	Additional Paid-in Capital Solfice Research, Inc.	Additional Paid-in Capital TPK Universal Solutions Limited	Additional Paid-in Capital Equity Financing Program	Accumulated Other Comprehensive Loss	Treasury Stock	Accumulated Deficit	Class A Common Stock	Class A Common Stock Equity Financing Program	Class A Common Stock Common Stock	Class A Common Stock Common Stock Freedom Photonics LLC	Class A Common Stock Common Stock Solfice Research, Inc.	Class A Common Stock Common Stock TPK Universal Solutions Limited	Class A Common Stock Common Stock Equity Financing Program	Class B Common Stock	Class B Common Stock Common Stock
Beginning balance (in shares) at Dec. 31, 2021																	266,076,525						97,088,670
Beginning balance at Dec. 31, 2021	$ 197,985						$ 1,257,214					$ (908)	$ (235,871)	$ (822,487)			$ 27						$ 10
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares repurchased	(76,606)												(76,606)
Issuance of Class A common stock upon exercise of Public and Private Warrants (in shares)																	405,752
Issuance of Class A common stock upon exercise of Private Warrants	19,003						19,003
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in shares)																	6,920,617
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units	2,846						2,845										$ 1
Retirement of unvested restricted common stock (in shares)																	(48,204)
Retirement of unvested restricted common stock	0
Vendor payments under the stock-in-lieu of cash program (in shares)																	9,574,385
Vendor payments under the stock-in-lieu of cash program	60,678						60,677										$ 1
Optogration milestone awards (in shares)																	1,632,056
Optogration milestone awards	11,751						11,751
Consideration related to acquisitions (in shares)																		2,176,205	374,193
Consideration related to acquisitions		$ 30,510	$ 3,361					$ 30,510	$ 3,361
Share-based compensation	102,408						102,408
Payments of employee taxes related to stock-based awards	(2,773)						(2,773)
Other comprehensive income (loss)	(5,081)											(5,081)
Net loss	(301,122)													(301,122)
Ending balance (in shares) at Sep. 30, 2022																	287,111,529						97,088,670
Ending balance at Sep. 30, 2022	42,960						1,484,996					(5,989)	(312,477)	(1,123,609)			$ 29						$ 10
Beginning balance (in shares) at Jun. 30, 2022																	282,211,182						97,088,670
Beginning balance at Jun. 30, 2022	88,561						1,413,064					(6,005)	(312,477)	(1,006,059)			$ 28						$ 10
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in shares)																	2,735,219
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units	1,102						1,101										$ 1
Retirement of unvested restricted common stock (in shares)																	(4,648)
Retirement of unvested restricted common stock	0
Vendor payments under the stock-in-lieu of cash program (in shares)																	537,720
Vendor payments under the stock-in-lieu of cash program	16,920						16,920
Optogration milestone awards (in shares)																	1,632,056
Optogration milestone awards	11,751						11,751
Share-based compensation	43,209						43,209
Payments of employee taxes related to stock-based awards	(1,049)						(1,049)
Other comprehensive income (loss)	16											16
Net loss	(117,550)													(117,550)
Ending balance (in shares) at Sep. 30, 2022																	287,111,529						97,088,670
Ending balance at Sep. 30, 2022	42,960						1,484,996					(5,989)	(312,477)	(1,123,609)			$ 29						$ 10
Beginning balance (in shares) at Dec. 31, 2022																	291,942,087						97,088,670
Beginning balance at Dec. 31, 2022	(26,405)						1,558,685					(4,226)	(312,477)	(1,268,426)			$ 29						$ 10
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in shares)																	13,414,078				5,599,121
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units	2,553				$ 38,711		2,551				$ 38,711					$ 38,700	$ 2
Issuance of Class A common stock under employee stock purchase plan (ESPP) (in shares)																	272,524
Issuance of Class A common stock under employee stock purchase plan (“ESPP”)	1,406						1,406
Issuance of Class A common stock to Plus (in shares)						1,926,471
Issuance of Class A common stock to Plus	12,141						12,141
Vendor payments under the stock-in-lieu of cash program (in shares)																	6,505,012
Vendor payments under the stock-in-lieu of cash program	43,329						43,328										$ 1
Milestone related to acquisitions (in shares)																	2,943,401
Milestone awards related to acquisitions	20,656						20,656
Consideration related to acquisitions (in shares)																				3,305,784
Consideration related to acquisitions				$ 20,000						$ 20,000
Share-based compensation	141,393						141,393
Payments of employee taxes related to stock-based awards	(572)						(572)
Other comprehensive income (loss)	3,991											3,991
Net loss	(422,868)													(422,868)
Ending balance (in shares) at Sep. 30, 2023															304,045,028		325,908,478					97,088,670	97,088,670
Ending balance at Sep. 30, 2023	(165,665)						1,838,299					(235)	(312,477)	(1,691,294)			$ 32						$ 10
Beginning balance (in shares) at Jun. 30, 2023																	313,888,629						97,088,670
Beginning balance at Jun. 30, 2023	(129,147)						1,741,053					(808)	(312,477)	(1,556,956)			$ 31						$ 10
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in shares)																	4,688,949			1,652,892	1,833,829
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units	904			$ 10,000	$ 9,107		903			$ 10,000	$ 9,107					$ 9,100
Issuance of Class A common stock to Plus (in shares)						1,926,471
Issuance of Class A common stock to Plus	12,141						12,141
Vendor payments under the stock-in-lieu of cash program (in shares)																	389,920
Vendor payments under the stock-in-lieu of cash program	9,734						9,734
Milestone related to acquisitions (in shares)																	1,527,788
Milestone awards related to acquisitions	11,336						11,336
Share-based compensation	44,025						44,025
Other comprehensive income (loss)	573											573
Net loss	(134,338)													(134,338)
Ending balance (in shares) at Sep. 30, 2023															304,045,028		325,908,478					97,088,670	97,088,670
Ending balance at Sep. 30, 2023	$ (165,665)						$ 1,838,299					$ (235)	$ (312,477)	$ (1,691,294)			$ 32						$ 10

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net loss	$ (422,868)	$ (301,122)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	19,468	4,374
Amortization of operating lease right-of-use assets	5,095	3,531
Amortization of premium (discount) on marketable securities	(3,952)	1,111
Loss on marketable securities	7,774	0
Change in fair value of private warrants	(1,345)	(6,645)
Vendor stock-in-lieu of cash program	31,487	32,487
Amortization of debt discount and issuance costs	2,427	2,427
Inventory write-offs and write-downs	17,343	8,750
Share-based compensation	160,031	117,874
Loss on investment in non-marketable securities	2,141	0
Product warranty and other	4,273	(623)
Changes in operating assets and liabilities:
Accounts receivable	(7,729)	6,457
Inventories	(25,249)	(6,648)
Prepaid expenses and other current assets	10,858	(4,685)
Other non-current assets	(3,458)	(1,371)
Accounts payable	4,018	8,379
Accrued and other current liabilities	14,379	5,716
Other non-current liabilities	(9,219)	(3,571)
Net cash used in operating activities	(194,526)	(133,559)
Cash flows from investing activities:
Purchases of marketable securities	(269,164)	(363,906)
Proceeds from maturities of marketable securities	390,836	254,068
Proceeds from sales/redemptions of marketable securities	51,569	68,804
Purchases of property and equipment	(21,129)	(11,277)
Advances for capital projects and equipment	0	(2,009)
Net cash provided by (used in) investing activities	139,504	(59,080)
Cash flows from financing activities:
Proceeds from exercise of stock options	2,560	2,891
Proceeds from sale of Class A common stock under ESPP	1,406	0
Payments of employee taxes related to stock-based awards	(572)	(2,773)
Repurchase of common stock	0	(80,878)
Net cash provided by (used in) financing activities	62,105	(80,760)
Net increase (decrease) in cash, cash equivalents and restricted cash	7,083	(273,399)
Beginning cash, cash equivalents and restricted cash	71,105	330,702
Ending cash, cash equivalents and restricted cash	78,188	57,303
Supplemental disclosures of cash flow information:
Cash paid for interest	3,906	3,863
Supplemental disclosures of noncash investing and financing activities:
Issuance of Class A common stock upon exercise of warrants	0	19,003
Operating lease right-of-use assets obtained in exchange for lease obligations	3,335	16,749
Purchases of property and equipment recorded in accounts payable and accrued liabilities	2,194	1,663
Vendor stock-in-lieu of cash program—advances for capital projects and equipment	7,411	21,024
Investment in Plus	10,000	0
Equity Financing Program
Cash flows from financing activities:
Proceeds from issuance of class A common stock	38,711	0
TPK Universal Solutions Limited
Cash flows from financing activities:
Proceeds from issuance of class A common stock	20,000	0
Freedom Photonics
Cash flows from investing activities:
Acquisition of Freedom Photonics LLC (net of cash acquired)	0	(2,759)
Solfice Research, Inc.
Cash flows from investing activities:
Acquisitions	0	(2,001)
Seagate
Cash flows from investing activities:
Acquisitions	$ (12,608)	$ 0

Organization and Description of

Organization and Description of Business	9 Months Ended
Organization and Description of Business	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	Organization and Description of Business Luminar Technologies, Inc. (together with its wholly owned subsidiaries, the “Company” or “Luminar”) is incorporated in Delaware. Luminar is a global automotive technology company ushering in a new era of vehicle safety and autonomy. Over the past decade, Luminar has been building from the chip-level up, its light detection and ranging sensor, or LiDAR , which is expected to meet the demanding performance, safety, reliability and cost requirements to enable next generation safety and autonomous capabilities for passenger and commercial vehicles as well as other adjacent markets.

Basis of Presentation and Summa

Basis of Presentation and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation and Summary of Significant Accounting Policies	Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Consolidation The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 (the “2022 Annual Report”) filed with the SEC on February 28, 2023. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. All intercompany transactions and balances have been eliminated in consolidation. Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosures. The significant estimates made by management include inventory reserves, useful life of long-lived assets, valuation allowance for deferred tax assets, valuation of warrants issued in a private placement (“Private Warrants”), valuation of assets acquired in mergers and acquisitions including intangible assets, forecasted costs associated with non-recurring engineering (“NRE”) services, product warranty reserves, stock-based compensation expense and other loss contingencies. Management periodically evaluates such estimates and they are adjusted prospectively based upon such periodic evaluation. Actual results could differ from those estimates. Segment Information The Company has determined its operating segments using the same indicators which are used to evaluate its performance internally. The Company’s business activities are organized in two operating segments: (i) “Autonomy Solutions,” which includes manufacturing and distribution of LiDAR sensors that measure distance using laser light to generate a 3D map, non-recurring engineering services related to the Company’s LiDAR products, development of software products that enable autonomy capabilities for automotive applications, and licensing of the Company’s intellectual property (“IP”). In January 2023, the Company acquired certain assets from Seagate Technology LLC and Seagate Singapore International Headquarters Pte. Ltd. (individually and collectively, “Seagate”). Assets purchased from Seagate have been included in the Autonomy Solutions segment. (ii) “Advanced Technologies and Services” (“ATS”), which includes development of application-specific integrated circuits, pixel-based sensors, advanced lasers, as well as designing, testing and providing consulting services for non-standard integrated circuits. Concentration of Credit Risk The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, debt securities and accounts receivable. The Company’s deposits exceed federally insured limits. Cash held by foreign subsidiaries of the Company as of September 30, 2023 and December 31, 2022 was not material. The Company’s revenue is derived from customers located in the United States and international markets. Two customers accounted for 56% and 13% of the Company’s accounts receivable as of September 30, 2023. Three customers accounted for 27%, 23% and 11% of the Company’s accounts receivable as of December 31, 2022. Significant Accounting Policies The Company’s significant accounting policies are disclosed in its Annual Report on Form 10-K for the year ended December 31, 2022. There has been no material change to the Company’s significant accounting policies during the nine months ended September 30, 2023. Recent Accounting Pronouncements Not Yet Effective The Company has reviewed, or is in the process of evaluating, all issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such accounting pronouncements will cause a material impact on its consolidated financial position, operating results or statements of cash flows.

Business Combinations and Acqui

Business Combinations and Acquisitions	9 Months Ended
Business Combinations and Acquisitions	Sep. 30, 2023
Business Combination and Asset Acquisition [Abstract]
Business Combinations and Acquisitions	Business Combinations and Acquisitions Acquisition of Seagate’s LiDAR Business On January 18, 2023, the Company acquired certain assets (including intellectual property (“IP”), equipment and other assets) and employees from Seagate Technology LLC and its affiliates (together “Seagate”). The Company simultaneously licensed IP from Seagate. The aggregate purchase price of $12.6 million for the said acquired assets and the license was paid in cash. The acquired assets and employees comprised Seagate’s LiDAR development operations and have been combined into the Company’s research and development team. This transaction has been accounted for as a business combination. Recording of Assets Acquired Price allocation includes estimates of fair value of certain working capital and deferred tax balances. During the second quarter ended June 30, 2023, the Company finalized its determination relating to the fair value of assets acquired from Seagate. The following table summarizes the purchase price allocation to assets acquired (in thousands): Recorded Value Property plant and equipment $ 3,163 Developed Technology (1) 8,240 Goodwill (2) 1,063 Other assets 142 Net assets acquired $ 12,608 (1) Technology and IP Licenses were measured using the cost approach. Significant inputs used as part of the valuation of intangible assets include personnel costs, overhead costs, developer’s profit, and expected time to reproduce. (2) Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected future economic benefits as a result of other assets acquired that could not be individually identified and separately recognized. Goodwill is not amortized. The factors that made up the goodwill recognized included workforce and expected synergies derived from the technology application to the Company’s current technological platforms. The entire amount of goodwill is expected to be deductible for tax purposes and is allocated to the Autonomy Solutions segment, which is also deemed the reporting unit. Identifiable intangible assets recognized (in thousands): Useful Life Recorded Value Developed technology 4 — 6 years $ 8,240 The acquired business did not contribute distinct revenues but added additional operating expenses primarily related to personnel-related costs of the hired team of former Seagate employees and related facilities costs in the period from January 18, 2023 to September 30, 2023. Such operating expenses were not material to the operating results of the Company for the three and nine months ended September 30, 2023.

Revenue

Revenue	9 Months Ended
Revenue	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Revenue	Revenue The Company’s revenue is comprised of sales of LiDAR sensors hardware, components, NRE services and licensing of certain information available with the Company. Disaggregation of Revenues The Company disaggregates its revenue from contracts with customers by (1) geographic region based on a customer’s billed to location, and (2) type of good or service and timing of transfer of goods or services to customers (point-in-time or over time), as it believes it best depicts how the nature, amount, timing and uncertainty of its revenue and cash flows are affected by economic factors. Total revenue based on the disaggregation criteria described above, as well as revenue by segment, are as follows (in thousands): Three Months Ended September 30, 2023 2022 Revenue % of Revenue Revenue % of Revenue Revenue by primary geographical market: North America $ 16,367 97 % $ 12,440 97 % Europe and Middle East and other 592 3 % 345 3 % Total $ 16,959 100 % $ 12,785 100 % Revenue by timing of recognition: Recognized at a point in time $ 10,753 63 % $ 6,728 53 % Recognized over time 6,206 37 % 6,057 47 % Total $ 16,959 100 % $ 12,785 100 % Revenue by segment: Autonomy Solutions $ 11,229 66 % $ 6,777 53 % ATS 5,730 34 % 6,008 47 % Total $ 16,959 100 % $ 12,785 100 % Nine Months Ended September 30, 2023 2022 Revenue % of Revenue Revenue % of Revenue Revenue by primary geographical market: North America $ 43,341 91 % $ 26,124 88 % Asia Pacific 1,022 2 % 2,960 10 % Europe and Middle East 3,302 7 % 488 2 % Total $ 47,665 100 % $ 29,572 100 % Revenue by timing of recognition: Recognized at a point in time $ 28,043 59 % $ 10,067 34 % Recognized over time 19,622 41 % 19,505 66 % Total $ 47,665 100 % $ 29,572 100 % Revenue by segment: Autonomy Solutions $ 31,640 66 % $ 16,854 57 % ATS 16,025 34 % 12,718 43 % Total $ 47,665 100 % $ 29,572 100 % Volvo Stock Purchase Warrant As disclosed in the Company’s 2022 Annual Report, the Company had previously issued certain stock purchase warrants (“Volvo Warrants”) to Volvo Car Technology Fund AB (“VCTF”) in connection with an engineering services contract. The Volvo Warrants vest and become exercisable in two tranches based on satisfaction of certain commercial milestones. The fair value of the first tranche of the Volvo Warrants was recorded as a reduction in revenue in 2021. The second tranche of the Volvo warrants will be recorded as reduction in revenue upon achievement of sales of a certain number of the Company’s sensors to Volvo for use in their commercial vehicles, which had not commenced as of the end of September 30, 2023. Contract assets and liabilities Changes in our contract assets and contract liabilities primarily result from the timing difference between our performance and the customer’s payment based on contractual terms. Contract assets primarily represent revenues recognized for performance obligations that have been satisfied but for which amounts have not been billed. Contract liabilities consist of the Company’s obligation to transfer goods or services to a customer for which the Company has received consideration from the customer. Customer advanced payments represent required customer payments in advance of product shipments. Customer advance payments are recognized in revenue as or when control of the performance obligation is transferred to the customer. The opening and closing balances of contract assets were as follows (in thousands): September 30, 2023 December 31, 2022 Contract assets, current $ 15,302 $ 15,395 Contract assets, non-current 2,081 2,575 Ending balance $ 17,383 $ 17,970 The significant changes in contract assets balances consisted of the following (in thousands): September 30, 2023 December 31, 2022 Beginning balance $ 17,970 $ 9,907 Amounts billed that were included in the contract assets beginning balance (8,379) (4,228) Revenue recognized for performance obligations that have been satisfied but for which amounts have not been billed 7,792 12,291 Ending balance $ 17,383 $ 17,970 The opening and closing balances of contract liabilities were as follows (in thousands): September 30, 2023 December 31, 2022 Contract liabilities, current $ 3,019 $ 1,993 Contract liabilities, non-current 250 1,015 Ending balance $ 3,269 $ 3,008 The significant changes in contract liabilities balances consisted of the following (in thousands): September 30, 2023 December 31, 2022 Beginning balance $ 3,008 $ 898 Revenue recognized that was included in the contract liabilities beginning balance (2,083) (489) Increase due to cash received and not recognized as revenue and billings in excess of revenue recognized during the period 2,344 2,599 Ending balance $ 3,269 $ 3,008 Remaining Performance Obligations Revenue allocated to remaining performance obligations was $23.0 million as of September 30, 2023 and includes amounts within contract liabilities. The Company expects to recognize approximately 80% of this revenue over the next 12 months and the remainder thereafter.

Investments

Investments	9 Months Ended
Investments	Sep. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Investments	Investments Debt Securities The Company’s investments in debt securities consisted of the following as of September 30, 2023 and December 31, 2022 (in thousands): September 30, 2023 Cost Gross Gross Fair Value U.S. treasury securities $ 205,977 $ 4 $ (189) $ 205,792 U.S. agency and government sponsored securities 5,691 1 (1) 5,691 Corporate bonds 31,570 — (50) 31,520 Total debt securities $ 243,238 $ 5 $ (240) $ 243,003 Included in cash and cash equivalents $ 5,015 $ 1 $ — $ 5,016 Included in marketable securities $ 238,223 $ 4 $ (240) $ 237,987 December 31, 2022 Cost Gross Gross Fair Value U.S. treasury securities $ 191,075 $ 3 $ (2,598) $ 188,480 U.S. agency and government sponsored securities 4,999 — (75) 4,924 Commercial paper 74,755 — (232) 74,523 Corporate bonds 111,123 — (1,214) 109,909 Asset-backed securities 11,945 — (110) 11,835 Total debt securities $ 393,897 $ 3 $ (4,229) $ 389,671 Included in marketable securities $ 393,897 $ 3 $ (4,229) $ 389,671 The following table presents the gross unrealized losses and the fair value for those debt securities that were in an unrealized loss position for less than 12 months as of September 30, 2023 and December 31, 2022 (in thousands): September 30, 2023 December 31, 2022 Gross Fair Value Gross Fair Value U.S. treasury securities $ (189) $ 158,051 $ (2,598) $ 158,888 U.S. agency and government sponsored securities (1) 2,969 (75) 4,924 Commercial paper — — (232) 74,523 Corporate bonds (50) 30,794 (1,214) 109,909 Asset-backed securities — — (110) 11,835 Total $ (240) $ 191,814 $ (4,229) $ 360,079 As of September 30, 2023, the total amortized cost basis of the Company’s available-for-sale securities exceeded its fair value by $0.2 million, which was primarily attributable to widening credit spreads and rising interest rates since purchase. The Company reviewed its available-for-sale securities and concluded that the decline in fair value was not related to credit losses and that it is more likely than not that the entire amortized cost of each security will be recoverable before the Company is required to sell them or when the security matures. Accordingly, during the three and nine months ended September 30, 2023, no allowance for credit losses was recorded and instead the unrealized losses are reported as a component of accumulated other comprehensive loss. Equity Investments The Company’s equity investments consisted of the following as of September 30, 2023 and December 31, 2022 (in thousands): Condensed Consolidated Balance Sheets Location September 30, 2023 December 31, 2022 Money market funds (1) Cash and cash equivalents $ 28,916 $ 42,056 Marketable equity investments (1) Marketable securities 8,255 29,643 Investment in non-marketable securities Other non-current assets 10,000 — Non-marketable equity investment measured using the measurement alternative (2) Other non-current assets 4,000 4,000 Total $ 51,171 $ 75,699 (1) Investments with readily determinable fair values. (2) Investment in privately held company without readily determinable fair value. In August 2023, the Company made an investment in a Simple Agreement for Future Equity (“SAFE”) of Plus Automation, Inc. (“Plus”) for consideration of $10.0 million, towards which the Company initially issued 1,490,313 shares of Class A common stock of the Company. In September 2023, the Company settled the consideration owed by issuing an additional 436,158 shares of Class A common stock. The Company’s investment in Plus represents less than 5% of Plus’s capitalization. The Company neither has a significant influence over Plus nor does its investment amount to a controlling financial interest in Plus. The Company assesses its non-marketable equity investments quarterly for impairment. Adjustments and impairments are recorded in other income (expense), net on the condensed consolidated statements of operations.

Financial Statement Components

Financial Statement Components	9 Months Ended
Financial Statement Components	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Financial Statement Components	Financial Statement Components Cash and Cash Equivalents Cash and cash equivalents consisted of the following (in thousands): September 30, 2023 December 31, 2022 Cash $ 40,791 $ 27,496 Money market funds 28,916 42,056 U.S. treasury securities 4,021 — U.S. agency and government sponsored securities 995 — Total cash and cash equivalents $ 74,723 $ 69,552 Inventory Inventory comprised of the following (in thousands): September 30, 2023 December 31, 2022 Raw materials $ 8,846 $ 3,614 Work-in-process 3,656 2,329 Finished goods 4,196 2,849 Total inventories, net $ 16,698 $ 8,792 The Company’s inventory write-offs and write-downs primarily due to obsolescence due to change in product design, lower of cost or market assessment, and other adjustments were $3.9 million and $17.3 million for the three and nine months ended September 30, 2023 and $4.0 million and $8.8 million for the three and nine months ended September 30, 2022, respectively. Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following (in thousands): September 30, 2023 December 31, 2022 Prepaid expenses $ 9,031 $ 15,653 Contract assets 15,302 15,395 Advance payments to vendors 2,109 7,919 Other receivables 2,947 5,236 Total prepaid expenses and other current assets $ 29,389 $ 44,203 Property and Equipment Property and equipment consisted of the following (in thousands): September 30, 2023 December 31, 2022 Machinery and equipment $ 59,495 $ 14,047 Computer hardware and software 8,777 6,797 Land 1,001 1,001 Leasehold improvements 20,539 885 Vehicles, including demonstration fleet 3,331 3,222 Furniture and fixtures 858 818 Construction in progress 4,891 13,642 Total property and equipment 98,892 40,412 Accumulated depreciation and amortization (26,245) (10,152) Total property and equipment, net $ 72,647 $ 30,260 Property and equipment capitalized under finance lease were not material. Depreciation and amortization expense associated with property and equipment was $10.8 million and $16.2 million for the three and nine months ended September 30, 2023 and $1.1 million and $2.8 million for the three and nine months ended September 30, 2022, respectively. The Company continually evaluates opportunities for optimizing its manufacturing processes and product design. In the second quarter of 2023 , the Company’s management began evaluating options for changing sourcing of certain sub-assemblies and components which is expected to reduce future per unit sensor manufacturing costs. In the third quarter of 2023, the Company finalized and committed to a plan to proceed with a change in its sourcing strategy. As a result, the Company has reduced the useful lives of the long-lived assets within the impacted asset group in line with when these assets are expected to be abandoned. The Company expects the transition to new suppliers to be completed in 2024. The reduction in the estimated useful lives of the impacted assets resulted in the Company recording $6.6 million of accelerated depreciation charges in the third quarter of 2023. Intangible Assets The following table summarizes the activity in the Company’s intangible assets (in thousands): September 30, 2023 December 31, 2022 Beginning of the period $ 22,077 $ 2,424 Additions 8,240 21,890 Amortization expense (3,258) (2,237) End of the period $ 27,059 $ 22,077 The components of intangible assets were as follows (in thousands): September 30, 2023 December 31, 2022 Gross Accumulated Net Weighted Average Gross Accumulated Net Weighted Customer relationships $ 3,730 $ (1,275) $ 2,455 3.8 $ 3,730 $ (664) $ 3,066 4.4 Customer backlog 650 (586) 64 0.2 650 (292) 358 0.9 Tradename 620 (307) 313 2.5 620 (214) 406 3.3 Assembled workforce 130 (130) — — 130 (130) — — Developed technology 20,150 (3,423) 16,727 5.7 11,910 (1,163) 10,747 7.5 IPR&D 7,500 — 7,500 — 7,500 — 7,500 — Total intangible assets $ 32,780 $ (5,721) $ 27,059 5.4 $ 24,540 $ (2,463) $ 22,077 6.6 Amortization expense related to intangible assets was $1.1 million and $3.3 million for the three and nine months ended September 30, 2023 and $0.7 million and $1.5 million for the three and nine months ended September 30, 2022, respectively. As of September 30, 2023, the expected future amortization expense for intangible assets was as follows (in thousands): Period Expected Future 2023 (remaining three months) $ 1,065 2024 4,001 2025 4,001 2026 3,354 2027 3,138 Thereafter 4,000 IPR&D 7,500 Total $ 27,059 Goodwill The carrying amount of goodwill allocated to the Company’s reportable segments was as follows (in thousands): Autonomy Solutions ATS Total Balance as of December 31, 2022 $ 687 $ 18,129 $ 18,816 Goodwill related to acquisition of Seagate’s lidar business (see Note 3) 1,063 — 1,063 Balance as of September 30, 2023 $ 1,750 $ 18,129 $ 19,879 Other Non-Current Assets Other non-current assets consisted of the following (in thousands): September 30, 2023 December 31, 2022 Security deposits $ 2,359 $ 5,495 Non-marketable equity investment (see Note 5 for additional information) 14,000 4,000 Advance payment for capital projects — 27,683 Deferred tax assets 3,780 — Contract assets 2,081 2,575 Other non-current assets 1,993 591 Total other non-current assets $ 24,213 $ 40,344 Accrued and Other Current Liabilities Accrued and other current liabilities consisted of the following (in thousands): September 30, 2023 December 31, 2022 Accrued compensation and benefits $ 19,463 $ 16,682 Accrued expenses 20,875 22,358 Contract losses 7,558 7,526 Warranty reserves 4,700 3,584 Contract liabilities 3,019 1,993 Accrued interest payable and other liabilities 2,874 819 Total accrued and other current liabilities $ 58,489 $ 52,962 During the three and nine months ended September 30, 2023, the Company recorded $3.9 million and $11.0 million, respectively, and $6.1 million and $10.6 million for the three and nine months ended September 30, 2022, respectively, in cost of sales (services) estimated losses expected to be incurred on NRE projects with certain customers. The estimated contract losses recorded were primarily a result of (a) changes in estimates related to costs expected to be incurred for contractual milestones based on actual experience on similar projects and (b) changes in scope of project deliverables agreed upon with the respective customers during the year.

Convertible Senior Notes and Ca

Convertible Senior Notes and Capped Call Transactions	9 Months Ended
Convertible Senior Notes and Capped Call Transactions	Sep. 30, 2023
Debt Disclosure [Abstract]
Convertible Senior Notes and Capped Call Transactions	Convertible Senior Notes and Capped Call Transactions In December 2021, the Company issued $625.0 million aggregate principal amount of 1.25% Convertible Senior Notes due 2026 in a private placement, which included $75.0 million aggregate principal amount of such notes pursuant to the exercise in full of the option granted to the initial purchasers to purchase additional notes (collectively, the “Convertible Senior Notes”). The interest on the Convertible Senior Notes is payable semi-annually in arrears on June 15 and December 15 of each year, beginning on June 15, 2022. The Convertible Senior Notes will mature on December 15, 2026, unless repurchased or redeemed earlier by the Company or converted pursuant to their terms. The total net proceeds from the debt offering, after deducting fees paid to the initial purchasers paid by the Company, was approximately $609.4 million. Each $1,000 principal amount of the Convertible Senior Notes is initially convertible into 50.0475 shares of the Company’s Class A common stock, par value $0.0001, which is equivalent to an initial conversion price of approximately $19.98 per share. The conversion rate is subject to adjustment upon the occurrence of certain specified events prior to the maturity date but will not be adjusted for any accrued and unpaid interest. In addition, following certain corporate events that occur prior to the maturity date or if the Company delivers a notice of redemption in respect of some or all of the Convertible Senior Notes, the Company will, under certain circumstances, increase the conversion rate of the Convertible Senior Notes for a holder who elects to convert its Convertible Senior Notes in connection with such a corporate event or convert its Convertible Senior Notes called for redemption during the related redemption period, as the case may be. The Convertible Senior Notes are redeemable, in whole or in part (subject to certain limitations), at the Company’s option at any time, and from time to time, on or after December 20, 2024, and on or before the 40th scheduled trading day immediately before the maturity date, at a cash redemption price equal to the principal amount of the Convertible Senior Notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date, but only if certain liquidity conditions are satisfied and the last reported sale price per share of the Class A common stock exceeds 130% of the conversion price on (1) each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the trading day immediately before the date the Company sends the related redemption notice, and (2) the trading day immediately before the date the Company sends such notice. If the Company undergoes a fundamental change (as defined in the indenture governing the Convertible Senior Notes) prior to the maturity date, holders may require the Company to repurchase for cash all or any portion of their Convertible Senior Notes in principal amounts of $1,000 or a multiple thereof at a fundamental change repurchase price equal to 100% of the principal amount of the Convertible Senior Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. Holders of the Convertible Senior Notes may convert their Convertible Senior Notes at their option at any time prior to the close of business on the business day immediately preceding December 15, 2026, in multiples of $1,000 principal amount, only under the following circumstances: (1) during any calendar quarter (and only during such calendar quarter) commencing after the calendar quarter ending on March 31, 2022, if the last reported sale price per share of the Class A common stock exceeds 130% of the conversion price for each of at least 20 trading days, whether or not consecutive, during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter; (2) during the five consecutive business days immediately after any 10 consecutive trading day period (such 10 consecutive trading day period, the “measurement period”) in which the trading price per $1,000 principal amount of Convertible Senior Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of the Class A common stock on such trading day and the conversion rate on such trading day; (3) upon the occurrence of specified corporate events or distributions on the Class A common stock; and (4) if the Convertible Senior Notes are called for redemption. On or after June 15, 2026, holders may convert all or any portion of their Convertible Senior Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date, regardless of the foregoing circumstances. Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of its Class A common stock or a combination of cash and shares of its Class A common stock, at the Company’s election. As of September 30, 2023, the conditions allowing holders of the Convertible Senior Notes to convert were not met. The Company currently intends to settle the principal amount of its outstanding Convertible Senior Notes in cash and any excess in shares of the Company’s Class A common stock. The Convertible Senior Notes are senior unsecured obligations and will rank equal in right of payment with the Company’s future senior unsecured indebtedness; senior in right of payment to the Company’s future indebtedness that is expressly subordinated to the Convertible Senior Notes; effectively subordinated to the Company’s existing and future secured indebtedness, to the extent of the value of the collateral securing that indebtedness; and structurally subordinated to all existing and future indebtedness and other liabilities, including trade payables, and (to the extent the Company is not a holder thereof) preferred equity, if any, of the Company’s subsidiaries. The Company has classified the Convertible Senior Notes as a non-current liability under the guidance in ASC 470-20, as amended by ASU 2020-06. Debt discount and issuance costs aggregating approximately $16.2 million were initially recorded as a reduction to the principal amount of the Convertible Senior Notes and is being amortized as interest expense on a straight line basis over the contractual terms of the notes. The Company estimates that the difference between amortizing the debt discounts and the issuance costs using the straight line method as compared to using the effective interest rate method is immaterial. The net carrying amount of the Convertible Senior Notes was as follows (in thousands): September 30, 2023 December 31, 2022 Principal $ 625,000 $ 625,000 Unamortized debt discount and issuance costs (10,381) (12,808) Net carrying amount $ 614,619 $ 612,192 The following table sets forth the interest expense recognized related to the Convertible Senior Notes (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Contractual interest expense $ 1,969 $ 1,969 $ 5,843 $ 5,843 Amortization of debt discount and issuance costs 809 809 2,427 2,427 Total interest expense $ 2,778 $ 2,778 $ 8,270 $ 8,270 The remaining term over which the debt discount and issuance costs will be amortized is 3.2 years. Contractual interest expense is reflected as a component of other income (expense) income, net in the accompanying condensed consolidated statement of operations for the three and nine months ended September 30, 2023 and 2022. In connection with the offering of the Convertible Senior Notes, the Company entered into privately negotiated capped call option transactions with certain counterparties (the “Capped Calls”). The Capped Calls each have an initial strike price of approximately $19.98 per share, subject to certain adjustments, which corresponds to the initial conversion price of the Convertible Senior Notes. The Capped Calls have initial cap prices of $30.16 per share, subject to certain adjustment events. The Capped Calls are generally intended to reduce the potential dilution to the Class A common stock upon any conversion of the Convertible Senior Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of converted Convertible Senior Notes, as the case may be, with such reduction and/or offset subject to a cap based on the cap price. The Capped Calls expire on April 6, 2027, subject to earlier exercise. The Capped Calls are subject to either adjustment or termination upon the occurrence of specified extraordinary events affecting the Company, including a merger event, a tender offer, and a nationalization, insolvency or delisting involving the Company. In addition, the Capped Calls are subject to certain specified additional disruption events that may give rise to a termination of the Capped Calls, including

Fair Value Measurements

Fair Value Measurements	9 Months Ended
Fair Value Measurements	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements As of September 30, 2023, the Company carried cash equivalents, marketable investments and Private Warrants that are measured at fair value on a recurring basis. Additionally, the Company measures its equity-settled fixed value awards at fair value on a recurring basis. See Note 11 for further information on the Company’s fixed value equity awards. Fair value is based on the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: Level 1 — Observable inputs, which include unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 — Observable inputs other than Level 1 inputs, such as quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 — Unobservable inputs that are supported by little or no market activity and that are based on management’s assumptions, including fair value measurements determined by using pricing models, discounted cash flow methodologies or similar techniques. The Company determined the fair value of its Level 1 financial instruments, which are traded in active markets, using quoted market prices for identical instruments. Marketable investments classified within Level 2 of the fair value hierarchy are valued based on other observable inputs, including broker or dealer quotations, alternative pricing sources or U.S. Government Treasury yield of appropriate term. When quoted prices in active markets for identical assets or liabilities are not available, the Company relies on non-binding quotes from its investment managers, which are based on proprietary valuation models of independent pricing services. These models generally use inputs such as observable market data, quoted market prices for similar instruments, historical pricing trends of a security as relative to its peers. To validate the fair value determination provided by its investment managers, the Company reviews the pricing movement in the context of overall market trends and trading information from its investment managers. The Company performs routine procedures such as comparing prices obtained from independent source to ensure that appropriate fair values are recorded. Given that the transfer of Private Warrants to anyone outside of a small group of individuals constituting the sponsors of Gores Metropoulos, Inc. would result in the Private Warrants having substantially the same terms as the Public Warrants, management determined that the fair value of each Private Warrant is the same as that of a Public Warrant, with an insignificant adjustment for short-term marketability restrictions. As of September 30, 2023, management determined the fair value of the Private Warrants using observable inputs in the Black-Scholes valuation model, which used the remaining term of warrants of 2.18 years volatility of 77.6% and a risk-free rate of 4.99%. Accordingly, the Private Warrants are classified as Level 3 financial instruments. The following table presents changes in Level 3 liabilities relating to Private Warrants measured at fair value (in thousands): Private Warrants Balance as of December 31, 2022 $ 3,005 Change in fair value of outstanding warrants (1,345) Balance as of September 30, 2023 $ 1,660 The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used for such measurements were as follows (in thousands): Fair Value (in thousands) Measured as of September 30, 2023: Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 28,916 $ — $ — $ 28,916 U.S. treasury securities 4,021 — — 4,021 U.S. agency and government sponsored securities — 995 — 995 Total cash equivalents $ 32,937 $ 995 $ — $ 33,932 Marketable investments: U.S. treasury securities $ 201,771 $ — $ — $ 201,771 U.S. agency and government sponsored securities — 4,696 — 4,696 Corporate bonds — 31,520 — 31,520 Marketable equity investments 8,255 — — 8,255 Total marketable investments $ 210,026 $ 36,216 $ — $ 246,242 Liabilities: Private Warrants $ — $ — $ 1,660 $ 1,660 Fair Value (in thousands) Measured as of December 31, 2022: Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 42,056 $ — $ — $ 42,056 Total cash equivalents $ 42,056 $ — $ — $ 42,056 Marketable investments: U.S. treasury securities $ 188,480 $ — $ — $ 188,480 U.S. agency and government sponsored securities — 4,924 — 4,924 Commercial paper — 74,523 — 74,523 Corporate bonds — 109,909 — 109,909 Asset-backed securities — 11,835 — 11,835 Marketable equity investments 29,643 — — 29,643 Total marketable investments $ 218,123 $ 201,191 $ — $ 419,314 Liabilities: Private Warrants $ — $ — $ 3,005 $ 3,005 As of September 30, 2023 and December 31, 2022, the estimated fair value of the Company’s outstanding Convertible Senior Notes was $409.4 million and $352.5 million, respectively. The fair value was determined based on the quoted price of the Convertible Senior Notes in an inactive market on the last trading day of the reporting period and have been classified as Level 2 in the fair value hierarchy. See Note 7 for further information on the Company’s Convertible Senior Notes. The fair value of Company’s other financial instruments, including accounts receivable, accounts payable and other current liabilities, approximate their carrying value due to the relatively short maturity of those instruments. The carrying amounts of the Company’s finance leases approximate their fair value, which is the present value of expected future cash payments based on assumptions about current interest rates and the creditworthiness of the Company.

Earnings (Loss) Per Share

Earnings (Loss) Per Share	9 Months Ended
Earnings (Loss) Per Share	Sep. 30, 2023
Earnings Per Share [Abstract]
Earnings (Loss) Per Share	Earnings (Loss) Per ShareBasic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Diluted earnings per share is computed by dividing net income by the weighted average number of shares of common stock during the period plus common stock equivalents, as calculated under the treasury stock method, outstanding during the period. If the Company reports a net loss, the computation of diluted loss per share excludes the effect of dilutive common stock equivalents, as their effect would be antidilutive. The Company computes earnings (loss) per share using the two-class method for its Class A and Class B common stock. Earnings (loss) per share is same for both Class A and Class B common stock since they are entitled to the same liquidation and dividend rights. The following table sets forth the computation of basic and diluted loss per share for the three and nine months ended September 30, 2023 and 2022 (in thousands, except for share and per share amounts): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Numerator: Net loss $ (134,338) $ (117,550) $ (422,868) $ (301,122) Denominator: Weighted average common shares outstanding—Basic 394,591,942 359,753,254 382,673,871 353,537,754 Weighted average common shares outstanding—Diluted 394,591,942 359,753,254 382,673,871 353,537,754 Net loss per share—Basic and Diluted $ (0.34) $ (0.33) $ (1.11) $ (0.85) The following table presents the potential shares of common stock outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive or related contingencies on issuance of shares had not been met as of September 30, 2023: September 30, 2023 Warrants 5,757,549 Stock-based awards—Equity classified 36,794,743 Stock-based awards—Liability classified 12,355,018 Vendor stock-in-lieu of cash program 565,476 Convertible Senior Notes 31,279,716 Earn-out shares 8,606,717 Total 95,359,219

Stockholders' Equity

Stockholders' Equity	9 Months Ended
Stockholders' Equity	Sep. 30, 2023
Equity [Abstract]
Stockholders' Equity	Stockholders’ Equity Class A and Class B Common Stock The Company’s board of directors (the “Board”) has authorized two classes of common stock, Class A and Class B. As of September 30, 2023, the Company had authorized 715,000,000 shares of Class A common stock and 121,000,000 shares of Class B common stock with a par value of $0.0001 per share for each class. As of September 30, 2023, the Company had 325,908,478 shares issued and 304,045,028 shares outstanding of Class A common stock, and 97,088,670 shares issued and outstanding of Class B common stock. Holders of Class A and Class B common stock have identical rights, except that holders of the Class A common stock are entitled to one vote per share and the holder of the Class B common stock is entitled to ten votes per share. Equity Financing Program On February 28, 2023, the Company entered into an agreement (the “Sales Agreement”) with Virtu Americas LLC (the “Agent”) under which the Company may offer and sell, from time to time in its sole discretion, shares of the Company’s Class A common stock with aggregate gross sales proceeds of up to $75.0 million through an equity offering program under which the Agent will act as sales agent (the “Equity Financing Program”). The Company intends to use the net proceeds from offerings under the Equity Financing Program primarily for expenditures or payments in connection with strategic merger and acquisition opportunities, as well as potential strategic investments, partnerships and similar transactions. Under the Sales Agreement, the Company sets the parameters for the sale of the shares, including the number of shares to be issued, the time period during which sales are requested to be made, limitations on the number of shares that may be sold in any one trading day and any minimum price below which sales may not be made. Subject to the terms and conditions of the Sales Agreement, the Agent has agreed to use its commercially reasonable efforts, consistent with its normal trading and sales practices, to sell the shares by methods deemed to be an “at the market” offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended, (the “Securities Act”) including sales made through The Nasdaq Global Select Market. The Company issued 1,833,829 and 5,599,121 shares of Class A common stock under the Equity Financing Program during the three and nine months ended September 30, 2023 for net proceeds of $9.1 million and $38.7 million, respectively. As of September 30, 2023, $35.9 million of Class A common stock was available for sale under the program. Strategic Investment Agreement On May 8, 2023, the Company entered into an agreement to issue 1,652,892 shares of Class A common stock to a wholly owned subsidiary of TPK, for a cash purchase price of $10.0 million pursuant to a private placement in reliance on Section 4(a)(2) of the Securities Act. The Company received proceeds of $10.0 million and issued 1,652,892 shares of Class A common stock on May 15, 2023. Additionally, the Company had granted an option to purchase 1,652,892 additional shares of Class A common stock worth $10.0 million, which was exercised on August 9, 2023. Private Warrants The Company had 1,668,269 Private Warrants outstanding as of December 31, 2022. No Private Warrants were exercised in the nine months ended September 30, 2023. The Private Warrants are set to expire on December 2, 2025. Each Private Warrant allows the holder to purchase one share of Class A common stock at $11.50 per share. Stock-in-lieu of Cash Program The Company has entered into arrangements with certain vendors and other third parties wherein the Company at its discretion may elect to compensate the respective vendors / third parties for services provided in either cash or by issuing shares of the Company’s Class A common stock (“Stock-in-lieu of Cash Program”). The Company considers the shares issuable under the Stock-in-lieu of Cash Program as liability classified awards when the arrangement with the vendors requires the Company to issue a variable number of shares to settle amounts owed. During the nine months ended September 30, 2023, the Company issued 6,505,012 shares of Class A common stock as part of the Stock-in-lieu of Cash Program, including 1,564,822 shares of Class A common stock in lieu of cash to a certain vendor for purchases of certain data, hardware and software pursuant to a private placement. As of September 30, 2023, the Company had a total of $6.1 million in prepaid expenses and other current and non-current assets related to its Stock-in-lieu of Cash Program. The Company’s vendor Stock-in-lieu of Cash Program activity for the nine months ended September 30, 2023 was as follows: Shares Weighted Average Unvested shares as of December 31, 2022 1,047,151 $ 11.90 Granted 6,505,012 6.13 Vested (6,038,523) 6.55 Unvested shares as of September 30, 2023 1,513,640 8.45

Stock-based Compensation

Stock-based Compensation	9 Months Ended
Stock-based Compensation	Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]
Stock-based Compensation	Stock-based Compensation Prior to becoming a publicly traded entity, the Company issued incentive stock options, non-qualified stock options, and restricted stock to employees and non-employee consultants under its 2015 Stock Plan (the “2015 Plan”). Since the closing of the business combination between Gores Metropoulos, Inc. and Luminar Technologies, Inc. on December 2, 2020 (the “Business Combination”), the Company has not issued any new stock-based awards under the 2015 Plan. In December 2020, the Board adopted, and the Company’s stockholders approved the 2020 Equity Incentive Plan (the “2020 Plan”). The 2020 Plan became effective upon the closing of the Business Combination. Under the 2020 Plan, the Company was originally authorized to issue a maximum number of 36,588,278 shares of Class A common stock. In June 2022, the Company’s stockholders approved an amendment and restatement of the Company’s 2020 Plan (the “Amended 2020 Plan”) to increase the number of shares of Class A common stock authorized for issuance by 36,000,000 additional shares and added an evergreen provision under which the number of shares of Class A common stock available for issuance under the Amended 2020 Plan will be increased on the first day of each fiscal year of the Company beginning with the 2023 fiscal year and ending on (and including) the first day of the 2030 fiscal year, in an amount equal to the lesser of (i) 5% of the outstanding shares of common stock on the last day of the immediately preceding fiscal year, (ii) 40,000,000 shares or (iii) such number of shares determined by the Board. Pursuant to the evergreen provision, 18,358,365 additional shares of Class A common stock were added to the Amended 2020 Plan on January 1, 2023. Stock Options Under the terms of the 2015 Plan, incentive stock options had an exercise price at or above the fair market value of the stock on the date of the grant, while non-qualified stock options were permitted to be granted below fair market value of the stock on the date of grant. Stock options granted have service-based vesting conditions only. The service-based vesting conditions vary, though typically, stock options vest over four years with 25% of stock options vesting on the first anniversary of the grant and the remaining 75% vesting monthly over the remaining 36 months. Option holders have a 10-year period to exercise their options before they expire. Forfeitures are recognized in the period of occurrence. The Company’s stock option activity for the nine months ended September 30, 2023 was as follows: Number of Weighted- Weighted- Aggregate Outstanding as of December 31, 2022 8,162,850 $ 1.74 Exercised (1,528,472) 1.67 Cancelled/Forfeited (125,909) 1.67 Outstanding as of September 30, 2023 6,508,469 1.76 6.33 $ 18,342 The aggregate intrinsic value of stock options exercised during the nine months ended September 30, 2023 was $7.4 million. The intrinsic value is calculated as the difference between the exercise price and the fair value of the common stock on the exercise date. The total grant-date fair value of stock options vested during the nine months ended September 30, 2023 was $1.6 million. Restricted Stock Awards Prior to June 30, 2019, the Company granted restricted stock awards (“RSAs”) to employees. Recipients purchased the restricted stock on the grant date and the Company has the right to repurchase the restricted shares at the same price recipients paid to obtain those shares. The restrictions lapse solely based on continued service, and generally lapse over 4 years —25% on the first anniversary of the date of issuance, and the remaining 75% monthly over the remaining 36 months. At the grant date of the award, recipients of restricted stock are granted voting rights and receive dividends on unvested shares. No restricted stock awards have been granted since June 30, 2019. The Company’s RSAs activity for the nine months ended September 30, 2023 was as follows: Shares Weighted Average Outstanding as of December 31, 2022 64,486 $ 1.29 Vested (64,486) 1.29 Outstanding as of September 30, 2023 — — Restricted Stock units Since the closing of the Business Combination, the Company has granted restricted stock units (“RSUs”) under the Amended 2020 Plan (and prior to its amendment and restatement, under the 2020 Plan). Each RSU granted under the Amended 2020 Plan represents a right to receive one share of the Company’s Class A common stock when the RSU vests. RSUs generally vest over a period up to six years. The Company has granted certain performance-based equity awards that vest upon achievement of certain performance milestones. The fair value of RSUs is equal to the fair value of the Company’s common stock on the date of grant. The Company’s Time-Based RSUs and Performance-Based and Other RSUs activity for the nine months ended September 30, 2023 was as follows: Time-Based RSUs Performance-Based and Other RSUs Shares Weighted Average Shares Weighted Average Outstanding as of December 31, 2022 25,010,688 $ 12.76 583,347 $ 8.39 Granted 19,351,770 6.75 961,187 8.58 Forfeited (3,038,849) 11.07 (750,301) 8.15 Vested (11,376,691) 11.01 (284,046) 7.45 Change in units based on performance — — (206,785) 9.65 Outstanding as of September 30, 2023 29,946,918 9.71 303,402 9.60 Fixed Value Equity Awards The Company issues fixed value equity awards to certain employees as a part of their compensation package. These awards are issued as RSUs under the Amended 2020 Plan (and prior to its amendment and restatement, under the 2020 Plan) and are accounted for as liability classified awards under ASC 718 — Stock Compensation. Fixed value equity awards granted have service-based conditions only and vest quarterly over a period of up to four years. These awards represent a fixed dollar amount settled in a variable number of shares determined at each vesting period. Stock-based compensation expense related to these awards was $4.2 million and $10.1 million for the three and nine months ended September 30, 2023, respectively, and $1.9 million and $5.4 million for the three and nine months ended September 30, 2022, respectively. Optogration Milestone Awards As part of the acquisition of Optogration, Inc. in August 2021, the Company owed up to $22.0 million of post combination compensation related to certain service and performance conditions (“Optogration Milestone Awards”). In August 2022, the Company issued 1,632,056 shares of Class A common stock for $11.0 million of the Optogration Milestone Awards and in August 2023, the Company issued 1,527,788 shares of Class A common stock for the remaining $11.0 million obligation. Freedom Photonics Awards As part of the acquisition of Freedom Photonics LLC (“Freedom Photonics”) in April 2022, the Company owed up to $29.8 million of post combination compensation related to certain service and performance conditions including achievement of certain technical and financial milestones. In May 2023, the Company issued 634,994 shares of Class A common stock and 492,176 RSUs for $3.9 million and $3.5 million, respectively, of the post combination compensation due to achievement of the service and performance conditions. As of September 30, 2023, it is probable that the remaining conditions will be met for an amount equal to approximately $20.9 million of post combination compensation. Solfice Awards The service and performance conditions related to the post combination compensation associated with the acquisition of certain assets from Solfice Research, Inc. (“Solfice”) were met in June 2023. Management Awards On May 2, 2022, the Board granted an award of 10.8 million RSUs to Austin Russell, the Company’s Chief Executive Officer. The grant date fair value per share of the award granted to Mr. Russell was $8.70 per share. On August 19, 2022, the Board granted 500,000 RSUs to each of Thomas Fennimore, the Company’s Chief Financial Officer, and Alan Prescott, the Company’s Chief Legal Officer. The grant date fair value per share of the awards granted to Mr. Fennimore and Mr. Prescott was $6.12 per share. These awards to Mr. Russell, Mr. Fennimore and Mr. Prescott are subject to all of the following vesting conditions: • Public Market condition: Achievement of three stock price milestones: $50 or more, $60 or more, and $70 or more. The stock price will be measured based on the volume-weighted average price per share for 90 consecutive trading days; • Service condition: Approximately 7-years of vesting; and • Performance condition: Start of production for at least one series production program. On March 16, 2023, the Board granted a $12.0 million stock-price based award to the Company’s Executive Vice President & General Manager that vested in six tranches of $2.0 million each, upon achievement of the six stock price milestones of $20, $25, $30, $40, $50 and $60 based on 90 trading day volume-weighted average price of a share of common stock over a 7.0 years performance period. The grant date fair value per share of the award granted to the said executive was $8.58 per share. On June 20, 2023, this award was modified to settle in a fixed number of shares and the impact of modification was not material. In September 2023, this award was forfeited and the impact of forfeiture was not material. The Company measured the compensation cost for the management awards outlined above using a Monte Carlo simulation model and recorded $5.6 million and $16.9 million in stock-based compensation expense related to these awards in the three and nine months ended September 30, 2023, respectively. The Company’s management awards activity for the nine months ended September 30, 2023 was as follows: Shares Weighted Average Outstanding as of December 31, 2022 11,800,000 $ 8.48 Granted 370,000 6.80 Forfeited (370,000) 6.80 Outstanding as of September 30, 2023 11,800,000 8.48 Compensation expense Stock-based compensation expense by function was as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Cost of sales $ 2,255 $ 5,430 $ 6,842 $ 14,205 Research and development 12,886 11,326 50,898 27,142 Sales and marketing 6,536 3,821 22,156 9,430 General and administrative 23,205 31,974 80,135 67,097 Total $ 44,882 $ 52,551 $ 160,031 $ 117,874 Stock-based compensation expense by type of award was as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Equity Classified Awards: Stock options $ 491 $ 714 $ 1,752 $ 1,984 RSAs — 162 61 183 RSUs 33,593 33,930 106,631 84,484 Management awards 5,560 5,522 17,059 9,017 ESPP 402 293 1,150 450 Liability Classified Awards: Equity-settled fixed value 4,150 1,894 10,066 5,013 Optogration 495 5,312 6,154 8,759 Freedom Photonics 687 3,155 10,219 5,955 Other (496) 1,569 6,939 2,029 Total $ 44,882 $ 52,551 $ 160,031 $ 117,874

Income Taxes

Income Taxes	9 Months Ended
Income Taxes	Sep. 30, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Provision for income taxes for the three and nine months ended September 30, 2023 and 2022 was not material. The effective tax rate was 0.1% and 0.2% for the nine months ended September 30, 2023 and 2022, respectively . The effective tax rates differ significantly from the statutory tax rate of 21%, primarily due to the Company’s valuation allowance movement in each period presented.

Leases

Leases	9 Months Ended
Leases	Sep. 30, 2023
Leases [Abstract]
Leases	Leases The Company leases office and manufacturing facilities under non-cancelable operating leases expiring at various dates through November 2028. Some of the Company’s leases include one or more options to renew, with renewal terms that if exercised by the Company, extend the lease term from one The components of lease expenses were as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Operating lease cost $ 2,111 $ 1,722 $ 6,111 $ 4,435 Variable lease cost 494 546 1,528 1,616 Total operating lease cost $ 2,605 $ 2,268 $ 7,639 $ 6,051 Supplemental cash flow information related to leases was as follows (in thousands): Nine Months Ended September 30, 2023 2022 Cash paid for amounts included in the measurement of lease liabilities: Cash paid for operating leases included in operating activities $ (5,358) $ (4,430) Right of use assets obtained in exchange for lease obligations: Operating leases 3,335 16,749 Supplemental balance sheet information related to leases was as follows (in thousands): September 30, 2023 December 31, 2022 Operating leases: Operating lease right-of-use assets $ 19,660 $ 21,244 Operating lease liabilities: Operating lease liabilities, current $ 6,475 $ 5,953 Operating lease liabilities, non-current 15,551 16,989 Total operating lease liabilities $ 22,026 $ 22,942 Weighted average remaining terms were as follows (in years): September 30, 2023 December 31, 2022 Weighted average remaining lease term Operating leases 4.01 4.43 Weighted average discount rates were as follows: September 30, 2023 December 31, 2022 Weighted average discount rate Operating leases 5.97 % 5.45 % Maturities of lease liabilities were as follows (in thousands): Operating Leases Year Ending December 31, 2023 (remaining three months) $ 1,951 2024 6,123 2025 5,789 2026 5,310 2027 4,208 2028 1,363 Total lease payments 24,744 Less: imputed interest (2,718) Total leases liabilities $ 22,026
Leases	Leases The Company leases office and manufacturing facilities under non-cancelable operating leases expiring at various dates through November 2028. Some of the Company’s leases include one or more options to renew, with renewal terms that if exercised by the Company, extend the lease term from one The components of lease expenses were as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Operating lease cost $ 2,111 $ 1,722 $ 6,111 $ 4,435 Variable lease cost 494 546 1,528 1,616 Total operating lease cost $ 2,605 $ 2,268 $ 7,639 $ 6,051 Supplemental cash flow information related to leases was as follows (in thousands): Nine Months Ended September 30, 2023 2022 Cash paid for amounts included in the measurement of lease liabilities: Cash paid for operating leases included in operating activities $ (5,358) $ (4,430) Right of use assets obtained in exchange for lease obligations: Operating leases 3,335 16,749 Supplemental balance sheet information related to leases was as follows (in thousands): September 30, 2023 December 31, 2022 Operating leases: Operating lease right-of-use assets $ 19,660 $ 21,244 Operating lease liabilities: Operating lease liabilities, current $ 6,475 $ 5,953 Operating lease liabilities, non-current 15,551 16,989 Total operating lease liabilities $ 22,026 $ 22,942 Weighted average remaining terms were as follows (in years): September 30, 2023 December 31, 2022 Weighted average remaining lease term Operating leases 4.01 4.43 Weighted average discount rates were as follows: September 30, 2023 December 31, 2022 Weighted average discount rate Operating leases 5.97 % 5.45 % Maturities of lease liabilities were as follows (in thousands): Operating Leases Year Ending December 31, 2023 (remaining three months) $ 1,951 2024 6,123 2025 5,789 2026 5,310 2027 4,208 2028 1,363 Total lease payments 24,744 Less: imputed interest (2,718) Total leases liabilities $ 22,026

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Purchase and Other Obligations The Company purchases goods and services from a variety of suppliers in the ordinary course of business. Purchase obligations are defined as agreements that are enforceable and legally binding and that specify all significant terms, including fixed or minimum quantities to be purchased, fixed, minimum, or variable price provisions, and the approximate timing of the transaction. The Company had purchase obligations primarily for purchases of inventory, R&D, and general and administrative activities totaling $104.1 million as of September 30, 2023. Legal Matters From time to time, the Company is involved in actions, claims, suits and other proceedings in the ordinary course of business, including assertions by third parties relating to intellectual property infringement, breaches of contract or warranties or employment-related matters. When it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated, the Company records a liability for such loss contingencies. The Company’s estimates regarding potential losses and materiality are based on the Company’s judgment and assessment of the claims utilizing currently available information. Although the Company will continue to reassess its reserves and estimates based on future developments, the Company’s objective assessment of the legal merits of such claims may not always be predictive of the outcome and actual results may vary from the Company’s current estimates. The Company’s current legal accrual is not material to the financial statements. On May 26, 2023, a putative class action styled Johnson v. Luminar Technologies, Inc., et al., Case No. 6:23-cv-00982-PGB-LHP, was filed in the United States District Court for the Middle District of Florida, against the Company and an employee. The suit asserts purported claims on behalf of purchasers of the Company’s securities between February 28, 2023 and March 17, 2023 under Sections 10(b) and 20(a) of the Exchange Act for allegedly misleading statements regarding the Company’s photonic integrated circuits technology. The Company disputes the allegations in the complaint and intends to vigorously defend the litigation. The Company presently does not expect this matter to have a material adverse impact on the Company’s financial results and did not accrue anything related to this matter as of September 30, 2023. On October 21, 2023, a shareholder derivative suit entitled Bhavsar v. McAuliffe, et al.

Segment and Customer Concentrat

Segment and Customer Concentration Information	9 Months Ended
Segment and Customer Concentration Information	Sep. 30, 2023
Segment Reporting [Abstract]
Segment and Customer Concentration Information	Segment and Customer Concentration Information Reportable segments are (i) Autonomy Solutions and (ii) ATS. These segments reflect the way the chief operating decision maker (“CODM”) evaluates the Company’s business performance and manages its operations. Each segment has distinct product offerings, customers and market penetration. The Chief Executive Officer is the CODM of the Company. Autonomy Solutions This segment manufactures and distributes commercial LiDAR sensors that measure distance using laser light for automotive mobility applications. This segment is impacted by trends in the autonomous vehicles and associated infrastructure/technology sector. ATS This segment is in the business of development of semiconductor technology based lasers and sensors. This segment also designs, tests and provides consulting services for development of integrated circuits. This segment is impacted by trends in and the strength of the automobile and aeronautics sector as well as government spending in military and defense activities. The accounting policies of the operating segments are the same as those described in Note 2. Segment operating results and reconciliations to the Company’s consolidated balances are as follows (in thousands): Three Months Ended September 30, 2023 Autonomy ATS Total Eliminations (1) Total Revenues from external customers $ 11,229 $ 5,730 $ 16,959 $ — $ 16,959 Depreciation and amortization 11,231 701 11,932 — 11,932 Operating income (loss) (131,943) 673 (131,270) 2,341 (128,929) Other significant items: Segment assets 676,874 79,237 756,111 (203,233) 552,878 Inventories, net 15,800 935 16,735 (37) 16,698 Three Months Ended September 30, 2022 Autonomy ATS Total Eliminations (1) Total Revenues from external customers $ 6,777 $ 6,008 $ 12,785 $ — $ 12,785 Depreciation and amortization 1,176 654 1,830 — 1,830 Operating income (loss) (116,601) 1,868 (114,733) (221) (114,954) Other significant items: Segment assets 765,241 53,000 818,241 (75,733) 742,508 Inventory 8,838 536 9,374 (221) 9,153 Nine Months Ended September 30, 2023 Autonomy ATS Total Eliminations (1) Total Revenues from external customers $ 31,640 $ 16,025 $ 47,665 $ — $ 47,665 Depreciation and amortization 17,423 2,045 19,468 — 19,468 Operating income (loss) (393,794) (22,157) (415,951) 1,235 (414,716) Other significant items: Segment assets 676,874 79,237 756,111 (203,233) 552,878 Inventory 15,800 935 16,735 (37) 16,698 Nine Months Ended September 30, 2022 Autonomy ATS Total Eliminations (1) Total Revenues from external customers $ 16,854 $ 12,718 $ 29,572 $ — $ 29,572 Depreciation and amortization 2,696 1,678 4,374 — 4,374 Operating income (loss) (304,370) 2,866 (301,504) (221) (301,725) Other significant items: Segment assets 765,241 53,000 818,241 (75,733) 742,508 Inventory 8,838 536 9,374 (221) 9,153 (1) Represents the eliminations of all intercompany balances and transactions during the period presented. Three customers, customers A, B and C of Autonomy Solutions segment, accounted for 32%, 14% and 14% of the Company’s revenue for the three months ended September 30, 2023. Two customers, customers A and B, accounted for 30% and 16% of the Company’s revenue for the nine months ended September 30, 2023. Two customers, customers A and B, accounted for 30% and 12% of the Company’s revenue for the three months ended September 30, 2022. Two customers, customers B and A, accounted for 25% and 13% of the Company’s revenue for the nine months ended September 30, 2022.

Subsequent Event

Subsequent Event	9 Months Ended
Subsequent Event	Sep. 30, 2023
Subsequent Events [Abstract]
Subsequent Event	Subsequent EventOn November 7, 2023, the Compensation Committee approved new cash and stock based awards for Thomas J. Fennimore, Chief Financial Officer and Alan Prescott, Chief Legal Officer. See Item 5 for details.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Pay vs Performance Disclosure
Net loss	$ (134,338)	$ (117,550)	$ (422,868)	$ (301,122)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	9 Months Ended
Insider Trading Arrangements	Sep. 30, 2023 shares	Sep. 30, 2023 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		During the quarter ended September 30, 2023, the following Section 16 officers adopted “Rule 10b5-1 trading arrangements” (as defined in Item 408 under Regulation S-K of the Exchange Act) as described in the table below, which were subsequently terminated on November 8, 2023: Name and Title Date Adopted Aggregate Number of Shares of Class A Common Stock to be Sold Pursuant to Trading Arrangement Duration Thomas J. Fennimore Chief Financial Officer September 15, 2023 Up to 375,000 shares of Class A common stock to be sold Until June 17, 2024 or earlier as provided in the Plan (1) Alan Prescott Chief Legal Officer September 19, 2023 Up to 180,000 shares of Class A common stock to be sold Until August 5, 2024 or earlier as provided in the Plan (1) (1) Plans were terminated on November 8, 2023.
Non-Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Terminated	false
Thomas J. Fennimore [Member]
Trading Arrangements, by Individual
Name	Thomas J. Fennimore
Title	Chief Financial Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 15, 2023
Rule 10b5-1 Arrangement Terminated	true
Termination Date	November 8, 2023
Arrangement Duration	54 days
Aggregate Available	375,000	375,000
Alan Prescott [Member]
Trading Arrangements, by Individual
Name	Alan Prescott
Title	Chief Legal Officer
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 19, 2023
Rule 10b5-1 Arrangement Terminated	true
Termination Date	November 8, 2023
Arrangement Duration	50 days
Aggregate Available	180,000	180,000

Basis of Presentation and Sum_2

Basis of Presentation and Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation and Consolidation	Basis of Presentation and Consolidation The accompanying condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (the “SEC”) regarding interim financial reporting. Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 (the “2022 Annual Report”) filed with the SEC on February 28, 2023. In the opinion of management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. All intercompany transactions and balances have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets, liabilities, equity, revenues and expenses, and related disclosures. The significant estimates made by management include inventory reserves, useful life of long-lived assets, valuation allowance for deferred tax assets, valuation of warrants issued in a private placement (“Private Warrants”), valuation of assets acquired in mergers and acquisitions including intangible assets, forecasted costs associated with non-recurring engineering (“NRE”) services, product warranty reserves, stock-based compensation expense and other loss contingencies. Management periodically evaluates such estimates and they are adjusted prospectively based upon such periodic evaluation. Actual results could differ from those estimates.
Segment Information	Segment Information The Company has determined its operating segments using the same indicators which are used to evaluate its performance internally. The Company’s business activities are organized in two operating segments: (i) “Autonomy Solutions,” which includes manufacturing and distribution of LiDAR sensors that measure distance using laser light to generate a 3D map, non-recurring engineering services related to the Company’s LiDAR products, development of software products that enable autonomy capabilities for automotive applications, and licensing of the Company’s intellectual property (“IP”). In January 2023, the Company acquired certain assets from Seagate Technology LLC and Seagate Singapore International Headquarters Pte. Ltd. (individually and collectively, “Seagate”). Assets purchased from Seagate have been included in the Autonomy Solutions segment. (ii) “Advanced Technologies and Services” (“ATS”), which includes development of application-specific integrated circuits, pixel-based sensors, advanced lasers, as well as designing, testing and providing consulting services for non-standard integrated circuits.
Concentration of Credit Risk	Concentration of Credit Risk The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents, debt securities and accounts receivable. The Company’s deposits exceed federally insured limits. Cash held by foreign subsidiaries of the Company as of September 30, 2023 and December 31, 2022 was not material.
Recent Accounting Pronouncements Not Yet Effective	Recent Accounting Pronouncements Not Yet Effective The Company has reviewed, or is in the process of evaluating, all issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such accounting pronouncements will cause a material impact on its consolidated financial position, operating results or statements of cash flows.
Fair Value Measurements	Fair Value Measurements As of September 30, 2023, the Company carried cash equivalents, marketable investments and Private Warrants that are measured at fair value on a recurring basis. Additionally, the Company measures its equity-settled fixed value awards at fair value on a recurring basis. See Note 11 for further information on the Company’s fixed value equity awards. Fair value is based on the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement: Level 1 — Observable inputs, which include unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 — Observable inputs other than Level 1 inputs, such as quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Level 3 — Unobservable inputs that are supported by little or no market activity and that are based on management’s assumptions, including fair value measurements determined by using pricing models, discounted cash flow methodologies or similar techniques. The Company determined the fair value of its Level 1 financial instruments, which are traded in active markets, using quoted market prices for identical instruments.

Business Combinations and Acq_2

Business Combinations and Acquisitions (Tables)	9 Months Ended
Business Combinations and Acquisitions (Tables)	Sep. 30, 2023
Business Combination and Asset Acquisition [Abstract]
Schedule of Purchase Price Allocation To Assets Acquired	The following table summarizes the purchase price allocation to assets acquired (in thousands): Recorded Value Property plant and equipment $ 3,163 Developed Technology (1) 8,240 Goodwill (2) 1,063 Other assets 142 Net assets acquired $ 12,608 (1) Technology and IP Licenses were measured using the cost approach. Significant inputs used as part of the valuation of intangible assets include personnel costs, overhead costs, developer’s profit, and expected time to reproduce. (2) Goodwill is the excess of the consideration transferred over the net assets recognized and represents the expected future economic benefits as a result of other assets acquired that could not be individually identified and separately recognized. Goodwill is not amortized. The factors that made up the goodwill recognized included workforce and expected synergies derived from the technology application to the Company’s current technological platforms. The entire amount of goodwill is expected to be deductible for tax purposes and is allocated to the Autonomy Solutions segment, which is also deemed the reporting unit.
Schedule of Finite-Lived Intangible Assets Acquired as Part of Asset Acquisition	Identifiable intangible assets recognized (in thousands): Useful Life Recorded Value Developed technology 4 — 6 years $ 8,240

Revenue (Tables)

Revenue (Tables)	9 Months Ended
Revenue (Tables)	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	Total revenue based on the disaggregation criteria described above, as well as revenue by segment, are as follows (in thousands): Three Months Ended September 30, 2023 2022 Revenue % of Revenue Revenue % of Revenue Revenue by primary geographical market: North America $ 16,367 97 % $ 12,440 97 % Europe and Middle East and other 592 3 % 345 3 % Total $ 16,959 100 % $ 12,785 100 % Revenue by timing of recognition: Recognized at a point in time $ 10,753 63 % $ 6,728 53 % Recognized over time 6,206 37 % 6,057 47 % Total $ 16,959 100 % $ 12,785 100 % Revenue by segment: Autonomy Solutions $ 11,229 66 % $ 6,777 53 % ATS 5,730 34 % 6,008 47 % Total $ 16,959 100 % $ 12,785 100 % Nine Months Ended September 30, 2023 2022 Revenue % of Revenue Revenue % of Revenue Revenue by primary geographical market: North America $ 43,341 91 % $ 26,124 88 % Asia Pacific 1,022 2 % 2,960 10 % Europe and Middle East 3,302 7 % 488 2 % Total $ 47,665 100 % $ 29,572 100 % Revenue by timing of recognition: Recognized at a point in time $ 28,043 59 % $ 10,067 34 % Recognized over time 19,622 41 % 19,505 66 % Total $ 47,665 100 % $ 29,572 100 % Revenue by segment: Autonomy Solutions $ 31,640 66 % $ 16,854 57 % ATS 16,025 34 % 12,718 43 % Total $ 47,665 100 % $ 29,572 100 %
Schedule of Opening and Closing Balances of Contract Liabilities and Significant Changes in Contract Liabilities	The opening and closing balances of contract assets were as follows (in thousands): September 30, 2023 December 31, 2022 Contract assets, current $ 15,302 $ 15,395 Contract assets, non-current 2,081 2,575 Ending balance $ 17,383 $ 17,970 The significant changes in contract assets balances consisted of the following (in thousands): September 30, 2023 December 31, 2022 Beginning balance $ 17,970 $ 9,907 Amounts billed that were included in the contract assets beginning balance (8,379) (4,228) Revenue recognized for performance obligations that have been satisfied but for which amounts have not been billed 7,792 12,291 Ending balance $ 17,383 $ 17,970 The opening and closing balances of contract liabilities were as follows (in thousands): September 30, 2023 December 31, 2022 Contract liabilities, current $ 3,019 $ 1,993 Contract liabilities, non-current 250 1,015 Ending balance $ 3,269 $ 3,008 The significant changes in contract liabilities balances consisted of the following (in thousands): September 30, 2023 December 31, 2022 Beginning balance $ 3,008 $ 898 Revenue recognized that was included in the contract liabilities beginning balance (2,083) (489) Increase due to cash received and not recognized as revenue and billings in excess of revenue recognized during the period 2,344 2,599 Ending balance $ 3,269 $ 3,008

Investments (Tables)

Investments (Tables)	9 Months Ended
Investments (Tables)	Sep. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Schedule of Debt Securities, Available-for-sale	The Company’s investments in debt securities consisted of the following as of September 30, 2023 and December 31, 2022 (in thousands): September 30, 2023 Cost Gross Gross Fair Value U.S. treasury securities $ 205,977 $ 4 $ (189) $ 205,792 U.S. agency and government sponsored securities 5,691 1 (1) 5,691 Corporate bonds 31,570 — (50) 31,520 Total debt securities $ 243,238 $ 5 $ (240) $ 243,003 Included in cash and cash equivalents $ 5,015 $ 1 $ — $ 5,016 Included in marketable securities $ 238,223 $ 4 $ (240) $ 237,987 December 31, 2022 Cost Gross Gross Fair Value U.S. treasury securities $ 191,075 $ 3 $ (2,598) $ 188,480 U.S. agency and government sponsored securities 4,999 — (75) 4,924 Commercial paper 74,755 — (232) 74,523 Corporate bonds 111,123 — (1,214) 109,909 Asset-backed securities 11,945 — (110) 11,835 Total debt securities $ 393,897 $ 3 $ (4,229) $ 389,671 Included in marketable securities $ 393,897 $ 3 $ (4,229) $ 389,671
Schedule of Gross Unrealized Losses and the Fair Value for Marketable Investments	The following table presents the gross unrealized losses and the fair value for those debt securities that were in an unrealized loss position for less than 12 months as of September 30, 2023 and December 31, 2022 (in thousands): September 30, 2023 December 31, 2022 Gross Fair Value Gross Fair Value U.S. treasury securities $ (189) $ 158,051 $ (2,598) $ 158,888 U.S. agency and government sponsored securities (1) 2,969 (75) 4,924 Commercial paper — — (232) 74,523 Corporate bonds (50) 30,794 (1,214) 109,909 Asset-backed securities — — (110) 11,835 Total $ (240) $ 191,814 $ (4,229) $ 360,079
Schedule of Equity Investments Included in Marketable Securities	The Company’s equity investments consisted of the following as of September 30, 2023 and December 31, 2022 (in thousands): Condensed Consolidated Balance Sheets Location September 30, 2023 December 31, 2022 Money market funds (1) Cash and cash equivalents $ 28,916 $ 42,056 Marketable equity investments (1) Marketable securities 8,255 29,643 Investment in non-marketable securities Other non-current assets 10,000 — Non-marketable equity investment measured using the measurement alternative (2) Other non-current assets 4,000 4,000 Total $ 51,171 $ 75,699 (1) Investments with readily determinable fair values. (2) Investment in privately held company without readily determinable fair value.

Financial Statement Components

Financial Statement Components (Tables)	9 Months Ended
Financial Statement Components (Tables)	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of Cash and Cash Equivalents	Cash and cash equivalents consisted of the following (in thousands): September 30, 2023 December 31, 2022 Cash $ 40,791 $ 27,496 Money market funds 28,916 42,056 U.S. treasury securities 4,021 — U.S. agency and government sponsored securities 995 — Total cash and cash equivalents $ 74,723 $ 69,552
Schedule of Inventories, net	Inventory comprised of the following (in thousands): September 30, 2023 December 31, 2022 Raw materials $ 8,846 $ 3,614 Work-in-process 3,656 2,329 Finished goods 4,196 2,849 Total inventories, net $ 16,698 $ 8,792
Schedule of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consisted of the following (in thousands): September 30, 2023 December 31, 2022 Prepaid expenses $ 9,031 $ 15,653 Contract assets 15,302 15,395 Advance payments to vendors 2,109 7,919 Other receivables 2,947 5,236 Total prepaid expenses and other current assets $ 29,389 $ 44,203
Schedule of Property and Equipment	Property and equipment consisted of the following (in thousands): September 30, 2023 December 31, 2022 Machinery and equipment $ 59,495 $ 14,047 Computer hardware and software 8,777 6,797 Land 1,001 1,001 Leasehold improvements 20,539 885 Vehicles, including demonstration fleet 3,331 3,222 Furniture and fixtures 858 818 Construction in progress 4,891 13,642 Total property and equipment 98,892 40,412 Accumulated depreciation and amortization (26,245) (10,152) Total property and equipment, net $ 72,647 $ 30,260
Schedule of Finite-Lived Intangible Assets	The following table summarizes the activity in the Company’s intangible assets (in thousands): September 30, 2023 December 31, 2022 Beginning of the period $ 22,077 $ 2,424 Additions 8,240 21,890 Amortization expense (3,258) (2,237) End of the period $ 27,059 $ 22,077 The components of intangible assets were as follows (in thousands): September 30, 2023 December 31, 2022 Gross Accumulated Net Weighted Average Gross Accumulated Net Weighted Customer relationships $ 3,730 $ (1,275) $ 2,455 3.8 $ 3,730 $ (664) $ 3,066 4.4 Customer backlog 650 (586) 64 0.2 650 (292) 358 0.9 Tradename 620 (307) 313 2.5 620 (214) 406 3.3 Assembled workforce 130 (130) — — 130 (130) — — Developed technology 20,150 (3,423) 16,727 5.7 11,910 (1,163) 10,747 7.5 IPR&D 7,500 — 7,500 — 7,500 — 7,500 — Total intangible assets $ 32,780 $ (5,721) $ 27,059 5.4 $ 24,540 $ (2,463) $ 22,077 6.6
Schedule of Future Amortization Expense	As of September 30, 2023, the expected future amortization expense for intangible assets was as follows (in thousands): Period Expected Future 2023 (remaining three months) $ 1,065 2024 4,001 2025 4,001 2026 3,354 2027 3,138 Thereafter 4,000 IPR&D 7,500 Total $ 27,059
Schedule of Goodwill	The carrying amount of goodwill allocated to the Company’s reportable segments was as follows (in thousands): Autonomy Solutions ATS Total Balance as of December 31, 2022 $ 687 $ 18,129 $ 18,816 Goodwill related to acquisition of Seagate’s lidar business (see Note 3) 1,063 — 1,063 Balance as of September 30, 2023 $ 1,750 $ 18,129 $ 19,879
Schedule of Other Noncurrent Assets	Other non-current assets consisted of the following (in thousands): September 30, 2023 December 31, 2022 Security deposits $ 2,359 $ 5,495 Non-marketable equity investment (see Note 5 for additional information) 14,000 4,000 Advance payment for capital projects — 27,683 Deferred tax assets 3,780 — Contract assets 2,081 2,575 Other non-current assets 1,993 591 Total other non-current assets $ 24,213 $ 40,344
Schedule of Accrued and Other Current Liabilities	Accrued and other current liabilities consisted of the following (in thousands): September 30, 2023 December 31, 2022 Accrued compensation and benefits $ 19,463 $ 16,682 Accrued expenses 20,875 22,358 Contract losses 7,558 7,526 Warranty reserves 4,700 3,584 Contract liabilities 3,019 1,993 Accrued interest payable and other liabilities 2,874 819 Total accrued and other current liabilities $ 58,489 $ 52,962

Convertible Senior Notes and _2

Convertible Senior Notes and Capped Call Transactions (Tables)	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Schedule of Net Carrying Amount	The net carrying amount of the Convertible Senior Notes was as follows (in thousands): September 30, 2023 December 31, 2022 Principal $ 625,000 $ 625,000 Unamortized debt discount and issuance costs (10,381) (12,808) Net carrying amount $ 614,619 $ 612,192
Schedule of Interest Expense	The following table sets forth the interest expense recognized related to the Convertible Senior Notes (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Contractual interest expense $ 1,969 $ 1,969 $ 5,843 $ 5,843 Amortization of debt discount and issuance costs 809 809 2,427 2,427 Total interest expense $ 2,778 $ 2,778 $ 8,270 $ 8,270

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
Fair Value Measurements (Tables)	Sep. 30, 2023
Fair Value Disclosures [Abstract]
Schedule of Changes in Level 3 Liabilities Measured at Fair Value	The following table presents changes in Level 3 liabilities relating to Private Warrants measured at fair value (in thousands): Private Warrants Balance as of December 31, 2022 $ 3,005 Change in fair value of outstanding warrants (1,345) Balance as of September 30, 2023 $ 1,660
Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements on a Recurring Basis and the Level of Inputs Used	The Company’s financial assets and liabilities subject to fair value measurements on a recurring basis and the level of inputs used for such measurements were as follows (in thousands): Fair Value (in thousands) Measured as of September 30, 2023: Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 28,916 $ — $ — $ 28,916 U.S. treasury securities 4,021 — — 4,021 U.S. agency and government sponsored securities — 995 — 995 Total cash equivalents $ 32,937 $ 995 $ — $ 33,932 Marketable investments: U.S. treasury securities $ 201,771 $ — $ — $ 201,771 U.S. agency and government sponsored securities — 4,696 — 4,696 Corporate bonds — 31,520 — 31,520 Marketable equity investments 8,255 — — 8,255 Total marketable investments $ 210,026 $ 36,216 $ — $ 246,242 Liabilities: Private Warrants $ — $ — $ 1,660 $ 1,660 Fair Value (in thousands) Measured as of December 31, 2022: Level 1 Level 2 Level 3 Total Assets: Cash equivalents: Money market funds $ 42,056 $ — $ — $ 42,056 Total cash equivalents $ 42,056 $ — $ — $ 42,056 Marketable investments: U.S. treasury securities $ 188,480 $ — $ — $ 188,480 U.S. agency and government sponsored securities — 4,924 — 4,924 Commercial paper — 74,523 — 74,523 Corporate bonds — 109,909 — 109,909 Asset-backed securities — 11,835 — 11,835 Marketable equity investments 29,643 — — 29,643 Total marketable investments $ 218,123 $ 201,191 $ — $ 419,314 Liabilities: Private Warrants $ — $ — $ 3,005 $ 3,005

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	9 Months Ended
Earnings (Loss) Per Share (Tables)	Sep. 30, 2023
Earnings Per Share [Abstract]
Schedule of Basic and Diluted Loss Per Share	The following table sets forth the computation of basic and diluted loss per share for the three and nine months ended September 30, 2023 and 2022 (in thousands, except for share and per share amounts): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Numerator: Net loss $ (134,338) $ (117,550) $ (422,868) $ (301,122) Denominator: Weighted average common shares outstanding—Basic 394,591,942 359,753,254 382,673,871 353,537,754 Weighted average common shares outstanding—Diluted 394,591,942 359,753,254 382,673,871 353,537,754 Net loss per share—Basic and Diluted $ (0.34) $ (0.33) $ (1.11) $ (0.85)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following table presents the potential shares of common stock outstanding that were excluded from the computation of diluted net loss per share of common stock as of the periods presented because including them would have been antidilutive or related contingencies on issuance of shares had not been met as of September 30, 2023: September 30, 2023 Warrants 5,757,549 Stock-based awards—Equity classified 36,794,743 Stock-based awards—Liability classified 12,355,018 Vendor stock-in-lieu of cash program 565,476 Convertible Senior Notes 31,279,716 Earn-out shares 8,606,717 Total 95,359,219

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	9 Months Ended
Stockholders' Equity (Tables)	Sep. 30, 2023
Equity [Abstract]
Schedule of Vendor Stock-in-lieu of Cash Program	The Company’s vendor Stock-in-lieu of Cash Program activity for the nine months ended September 30, 2023 was as follows: Shares Weighted Average Unvested shares as of December 31, 2022 1,047,151 $ 11.90 Granted 6,505,012 6.13 Vested (6,038,523) 6.55 Unvested shares as of September 30, 2023 1,513,640 8.45

Stock-based Compensation (Table

Stock-based Compensation (Tables)	9 Months Ended
Stock-based Compensation (Tables)	Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Option Activity	The Company’s stock option activity for the nine months ended September 30, 2023 was as follows: Number of Weighted- Weighted- Aggregate Outstanding as of December 31, 2022 8,162,850 $ 1.74 Exercised (1,528,472) 1.67 Cancelled/Forfeited (125,909) 1.67 Outstanding as of September 30, 2023 6,508,469 1.76 6.33 $ 18,342
Schedule of Restricted Stock Awards Activity	The Company’s RSAs activity for the nine months ended September 30, 2023 was as follows: Shares Weighted Average Outstanding as of December 31, 2022 64,486 $ 1.29 Vested (64,486) 1.29 Outstanding as of September 30, 2023 — — The Company’s Time-Based RSUs and Performance-Based and Other RSUs activity for the nine months ended September 30, 2023 was as follows: Time-Based RSUs Performance-Based and Other RSUs Shares Weighted Average Shares Weighted Average Outstanding as of December 31, 2022 25,010,688 $ 12.76 583,347 $ 8.39 Granted 19,351,770 6.75 961,187 8.58 Forfeited (3,038,849) 11.07 (750,301) 8.15 Vested (11,376,691) 11.01 (284,046) 7.45 Change in units based on performance — — (206,785) 9.65 Outstanding as of September 30, 2023 29,946,918 9.71 303,402 9.60 The Company’s management awards activity for the nine months ended September 30, 2023 was as follows: Shares Weighted Average Outstanding as of December 31, 2022 11,800,000 $ 8.48 Granted 370,000 6.80 Forfeited (370,000) 6.80 Outstanding as of September 30, 2023 11,800,000 8.48
Schedule of Stock-based Compensation Expense by Function	Stock-based compensation expense by function was as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Cost of sales $ 2,255 $ 5,430 $ 6,842 $ 14,205 Research and development 12,886 11,326 50,898 27,142 Sales and marketing 6,536 3,821 22,156 9,430 General and administrative 23,205 31,974 80,135 67,097 Total $ 44,882 $ 52,551 $ 160,031 $ 117,874 Stock-based compensation expense by type of award was as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Equity Classified Awards: Stock options $ 491 $ 714 $ 1,752 $ 1,984 RSAs — 162 61 183 RSUs 33,593 33,930 106,631 84,484 Management awards 5,560 5,522 17,059 9,017 ESPP 402 293 1,150 450 Liability Classified Awards: Equity-settled fixed value 4,150 1,894 10,066 5,013 Optogration 495 5,312 6,154 8,759 Freedom Photonics 687 3,155 10,219 5,955 Other (496) 1,569 6,939 2,029 Total $ 44,882 $ 52,551 $ 160,031 $ 117,874

Leases (Tables)

Leases (Tables)	9 Months Ended
Leases (Tables)	Sep. 30, 2023
Leases [Abstract]
Schedule of Components of Lease Expenses, Supplemental Cash Flow Information, Weighted Average Remaining Terms, and Weighted Average Discount Rates	The components of lease expenses were as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2023 2022 2023 2022 Operating lease cost $ 2,111 $ 1,722 $ 6,111 $ 4,435 Variable lease cost 494 546 1,528 1,616 Total operating lease cost $ 2,605 $ 2,268 $ 7,639 $ 6,051 Supplemental cash flow information related to leases was as follows (in thousands): Nine Months Ended September 30, 2023 2022 Cash paid for amounts included in the measurement of lease liabilities: Cash paid for operating leases included in operating activities $ (5,358) $ (4,430) Right of use assets obtained in exchange for lease obligations: Operating leases 3,335 16,749 Weighted average remaining terms were as follows (in years): September 30, 2023 December 31, 2022 Weighted average remaining lease term Operating leases 4.01 4.43 Weighted average discount rates were as follows: September 30, 2023 December 31, 2022 Weighted average discount rate Operating leases 5.97 % 5.45 %
Schedule of Supplemental Balance Sheet Information	Supplemental balance sheet information related to leases was as follows (in thousands): September 30, 2023 December 31, 2022 Operating leases: Operating lease right-of-use assets $ 19,660 $ 21,244 Operating lease liabilities: Operating lease liabilities, current $ 6,475 $ 5,953 Operating lease liabilities, non-current 15,551 16,989 Total operating lease liabilities $ 22,026 $ 22,942
Schedule of Maturities of Lease Liabilities	Maturities of lease liabilities were as follows (in thousands): Operating Leases Year Ending December 31, 2023 (remaining three months) $ 1,951 2024 6,123 2025 5,789 2026 5,310 2027 4,208 2028 1,363 Total lease payments 24,744 Less: imputed interest (2,718) Total leases liabilities $ 22,026

Segment and Customer Concentr_2

Segment and Customer Concentration Information (Tables)	9 Months Ended
Segment and Customer Concentration Information (Tables)	Sep. 30, 2023
Segment Reporting [Abstract]
Schedule of Segment Operating Results and Reconciliations to the Consolidated Balances	The accounting policies of the operating segments are the same as those described in Note 2. Segment operating results and reconciliations to the Company’s consolidated balances are as follows (in thousands): Three Months Ended September 30, 2023 Autonomy ATS Total Eliminations (1) Total Revenues from external customers $ 11,229 $ 5,730 $ 16,959 $ — $ 16,959 Depreciation and amortization 11,231 701 11,932 — 11,932 Operating income (loss) (131,943) 673 (131,270) 2,341 (128,929) Other significant items: Segment assets 676,874 79,237 756,111 (203,233) 552,878 Inventories, net 15,800 935 16,735 (37) 16,698 Three Months Ended September 30, 2022 Autonomy ATS Total Eliminations (1) Total Revenues from external customers $ 6,777 $ 6,008 $ 12,785 $ — $ 12,785 Depreciation and amortization 1,176 654 1,830 — 1,830 Operating income (loss) (116,601) 1,868 (114,733) (221) (114,954) Other significant items: Segment assets 765,241 53,000 818,241 (75,733) 742,508 Inventory 8,838 536 9,374 (221) 9,153 Nine Months Ended September 30, 2023 Autonomy ATS Total Eliminations (1) Total Revenues from external customers $ 31,640 $ 16,025 $ 47,665 $ — $ 47,665 Depreciation and amortization 17,423 2,045 19,468 — 19,468 Operating income (loss) (393,794) (22,157) (415,951) 1,235 (414,716) Other significant items: Segment assets 676,874 79,237 756,111 (203,233) 552,878 Inventory 15,800 935 16,735 (37) 16,698 Nine Months Ended September 30, 2022 Autonomy ATS Total Eliminations (1) Total Revenues from external customers $ 16,854 $ 12,718 $ 29,572 $ — $ 29,572 Depreciation and amortization 2,696 1,678 4,374 — 4,374 Operating income (loss) (304,370) 2,866 (301,504) (221) (301,725) Other significant items: Segment assets 765,241 53,000 818,241 (75,733) 742,508 Inventory 8,838 536 9,374 (221) 9,153 (1) Represents the eliminations of all intercompany balances and transactions during the period presented.

Basis of Presentation and Sum_3

Basis of Presentation and Summary of Significant Accounting Policies - Segment Information (Details)	9 Months Ended
	Sep. 30, 2023 operating_segment
Accounting Policies [Abstract]
Number of operating segments	2

Basis of Presentation and Sum_4

Basis of Presentation and Summary of Significant Accounting Policies - Concentration of Credit Risk (Details) - Accounts Receivable - Customer Concentration Risk	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Customer One
Concentration Risk [Line Items]
Percentage of accounts receivable (as percent)	56%	27%
Customer Two
Concentration Risk [Line Items]
Percentage of accounts receivable (as percent)	13%	23%
Customer Three
Concentration Risk [Line Items]
Percentage of accounts receivable (as percent)		11%

Business Combinations and Acq_3

Business Combinations and Acquisitions - Narrative (Details) $ in Millions	Jan. 18, 2023 USD ($)
Seagate
Business Acquisition [Line Items]
Asset acquisition, consideration transferred	$ 12.6

Business Combinations and Acq_4

Business Combinations and Acquisitions - Schedule of Purchase Price Allocation (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended	12 Months Ended
	Jun. 30, 2023	Sep. 30, 2023	Dec. 31, 2022
Business Acquisition [Line Items]
Finite-lived intangible assets acquired		$ 8,240	$ 21,890
Seagate
Business Acquisition [Line Items]
Property plant and equipment	$ 3,163
Goodwill		1,063
Other assets	142
Net assets acquired	12,608
Seagate \| Autonomy Solutions
Business Acquisition [Line Items]
Goodwill	1,063	$ 1,063
Seagate \| Developed technology
Business Acquisition [Line Items]
Finite-lived intangible assets acquired	$ 8,240

Business Combinations and Acq_5

Business Combinations and Acquisitions - Components of Intangible Assets and Estimated Useful Lives (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Jan. 18, 2023	Dec. 31, 2022
Business Acquisition [Line Items]
Useful Life	5 years 4 months 24 days		6 years 7 months 6 days
Developed technology
Business Acquisition [Line Items]
Useful Life	5 years 8 months 12 days		7 years 6 months
Recorded Value	$ 20,150		$ 11,910
Seagate \| Developed technology
Business Acquisition [Line Items]
Recorded Value		$ 8,240
Seagate \| Developed technology \| Minimum
Business Acquisition [Line Items]
Useful Life	4 years
Seagate \| Developed technology \| Maximum
Business Acquisition [Line Items]
Useful Life	6 years

Revenue - Schedule of Disaggreg

Revenue - Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 16,959	$ 12,785	$ 47,665	$ 29,572
Revenue from contract with customer benchmark \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	100%	100%	100%	100%
Revenue from contract with customer benchmark \| Revenue Recognition Timing Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	100%	100%	100%	100%
Revenue from contract with customer benchmark \| Segment Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	100%	100%	100%	100%
Autonomy Solutions
Disaggregation of Revenue [Line Items]
Revenue	$ 11,229	$ 6,777	$ 31,640	$ 16,854
Autonomy Solutions \| Revenue from contract with customer benchmark \| Segment Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	66%	53%	66%	57%
ATS
Disaggregation of Revenue [Line Items]
Revenue	$ 5,730	$ 6,008	$ 16,025	$ 12,718
ATS \| Revenue from contract with customer benchmark \| Segment Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	34%	47%	34%	43%
Recognized at a point in time
Disaggregation of Revenue [Line Items]
Revenue	$ 10,753	$ 6,728	$ 28,043	$ 10,067
Recognized at a point in time \| Revenue from contract with customer benchmark \| Revenue Recognition Timing Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	63%	53%	59%	34%
Recognized over time
Disaggregation of Revenue [Line Items]
Revenue	$ 6,206	$ 6,057	$ 19,622	$ 19,505
Recognized over time \| Revenue from contract with customer benchmark \| Revenue Recognition Timing Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	37%	47%	41%	66%
North America
Disaggregation of Revenue [Line Items]
Revenue	$ 16,367	$ 12,440	$ 43,341	$ 26,124
North America \| Revenue from contract with customer benchmark \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	97%	97%	91%	88%
Asia Pacific
Disaggregation of Revenue [Line Items]
Revenue			$ 1,022	$ 2,960
Asia Pacific \| Revenue from contract with customer benchmark \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)			2%	10%
Europe and Middle East and other
Disaggregation of Revenue [Line Items]
Revenue	$ 592	$ 345	$ 3,302	$ 488
Europe and Middle East and other \| Revenue from contract with customer benchmark \| Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
Percentage of revenue (as percent)	3%	3%	7%	2%

Revenue - Narrative (Details)

Revenue - Narrative (Details)	Mar. 31, 2020 tranche
VCTF warrant
Class of Warrant or Right [Line Items]
Number of tranches	2

Revenue - Schedule of Opening a

Revenue - Schedule of Opening and Closing Balances of Contract Assets and Contract Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Contract assets, current	$ 15,302	$ 15,395
Contract assets, non-current	2,081	2,575
Contract with customer, asset, total	17,383	17,970	$ 9,907
Contract liabilities, current	3,019	1,993
Contract liabilities, non-current	250	1,015
Contract with customer, liability, total	$ 3,269	$ 3,008	$ 898

Revenue - Schedule of Significa

Revenue - Schedule of Significant Changes in Contract Assets and Contract Liabilities (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Contract With Customer Asset [Roll Forward]
Beginning balance	$ 17,970	$ 9,907
Amounts billed that were included in the contract assets beginning balance	(8,379)	(4,228)
Revenue recognized for performance obligations that have been satisfied but for which amounts have not been billed	7,792	12,291
Ending balance	17,383	17,970
Contract with Customer, Liability [Roll Forward]
Beginning balance	3,008	898
Revenue recognized that was included in the contract liabilities beginning balance	(2,083)	(489)
Increase due to cash received and not recognized as revenue and billings in excess of revenue recognized during the period	2,344	2,599
Ending balance	$ 3,269	$ 3,008

Revenue - Remaining Performance

Revenue - Remaining Performance Obligations (Details) $ in Millions	Sep. 30, 2023 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 23
Revenue, remaining performance obligation, percentage	80%
Revenue, remaining performance obligation, period	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, period

Investments - Schedule of Debt

Investments - Schedule of Debt Securities, Available-for-sale (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Cost	$ 243,238	$ 393,897
Gross Unrealized Gains	5	3
Gross Unrealized Losses	(240)	(4,229)
Fair Value	243,003	389,671
Included in cash and cash equivalents
Debt Securities, Available-for-sale [Line Items]
Cost	5,015
Gross Unrealized Gains	1
Gross Unrealized Losses	0
Fair Value	5,016
Included in marketable securities
Debt Securities, Available-for-sale [Line Items]
Cost	238,223	393,897
Gross Unrealized Gains	4	3
Gross Unrealized Losses	(240)	(4,229)
Fair Value	237,987	389,671
U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Cost	205,977	191,075
Gross Unrealized Gains	4	3
Gross Unrealized Losses	(189)	(2,598)
Fair Value	205,792	188,480
U.S. agency and government sponsored securities
Debt Securities, Available-for-sale [Line Items]
Cost	5,691	4,999
Gross Unrealized Gains	1	0
Gross Unrealized Losses	(1)	(75)
Fair Value	5,691	4,924
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Cost		74,755
Gross Unrealized Gains		0
Gross Unrealized Losses		(232)
Fair Value		74,523
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Cost	31,570	111,123
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(50)	(1,214)
Fair Value	$ 31,520	109,909
Asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Cost		11,945
Gross Unrealized Gains		0
Gross Unrealized Losses		(110)
Fair Value		$ 11,835

Investments - Schedule of Gross

Investments - Schedule of Gross Unrealized Losses and the Fair Value for Marketable Investments (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Losses	$ (240)	$ (4,229)
Fair Value	191,814	360,079
U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Losses	(189)	(2,598)
Fair Value	158,051	158,888
U.S. agency and government sponsored securities
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Losses	(1)	(75)
Fair Value	2,969	4,924
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Losses	0	(232)
Fair Value	0	74,523
Corporate bonds
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Losses	(50)	(1,214)
Fair Value	30,794	109,909
Asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Gross Unrealized Losses	0	(110)
Fair Value	$ 0	$ 11,835

Investments - Narrative (Detail

Investments - Narrative (Details) - USD ($)	1 Months Ended
Investments - Narrative (Details) - USD ($)	Sep. 30, 2023	Aug. 31, 2023	Dec. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities in excess of fair value	$ 240,000		$ 4,229,000
Allowance for credit loss	$ 0
Robotic Research OpCo, LLC
Debt Securities, Available-for-sale [Line Items]
Equity method investment, ownership percentage (percent, less than)		5%
Robotic Research OpCo, LLC \| Class A Common Stock
Debt Securities, Available-for-sale [Line Items]
Stock consideration		$ 10,000,000
Common stock, shares issued (in shares)	436,158	1,490,313

Investments - Schedule of Equit

Investments - Schedule of Equity Investments (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Debt Securities, Available-for-sale [Line Items]
Total	$ 51,171	$ 75,699
Money market funds \| Cash and cash equivalents
Debt Securities, Available-for-sale [Line Items]
Marketable equity investments	28,916	42,056
Marketable equity investments \| Marketable securities
Debt Securities, Available-for-sale [Line Items]
Marketable equity investments	8,255	29,643
Investment in non-marketable securities \| Other non-current assets
Debt Securities, Available-for-sale [Line Items]
Non-marketable equity investment measured using the measurement alternative	10,000	0
Non-marketable equity investment \| Other non-current assets
Debt Securities, Available-for-sale [Line Items]
Non-marketable equity investment measured using the measurement alternative	$ 4,000	$ 4,000

Financial Statement Component_2

Financial Statement Components - Schedule of Cash and Cash Equivalents (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash	$ 40,791	$ 27,496
Money market funds	28,916	42,056
U.S. treasury securities	4,021	0
U.S. agency and government sponsored securities	995	0
Total cash and cash equivalents	$ 74,723	$ 69,552

Financial Statement Component_3

Financial Statement Components - Schedule of Inventories, net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Raw materials	$ 8,846		$ 8,846		$ 3,614
Work-in-process	3,656		3,656		2,329
Finished goods	4,196		4,196		2,849
Total inventories, net	16,698	$ 9,153	16,698	$ 9,153	$ 8,792
Inventory write-downs	$ 3,900	$ 4,000	$ 17,343	$ 8,750

Financial Statement Component_4

Financial Statement Components - Schedule of Prepaid Expenses and Other Current Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Prepaid expenses	$ 9,031	$ 15,653
Contract assets	15,302	15,395
Advance payments to vendors	2,109	7,919
Other receivables	2,947	5,236
Total prepaid expenses and other current assets	$ 29,389	$ 44,203

Financial Statement Component_5

Financial Statement Components - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 98,892		$ 98,892		$ 40,412
Accumulated depreciation and amortization	(26,245)		(26,245)		(10,152)
Total property and equipment, net	72,647		72,647		30,260
Depreciation and amortization	10,800	$ 1,100	16,200	$ 2,800
Restructuring and related cost, accelerated depreciation	6,600
Machinery and equipment
Property, Plant and Equipment [Line Items]
Total property and equipment	59,495		59,495		14,047
Computer hardware and software
Property, Plant and Equipment [Line Items]
Total property and equipment	8,777		8,777		6,797
Land
Property, Plant and Equipment [Line Items]
Total property and equipment	1,001		1,001		1,001
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment	20,539		20,539		885
Vehicles, including demonstration fleet
Property, Plant and Equipment [Line Items]
Total property and equipment	3,331		3,331		3,222
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment	858		858		818
Construction in progress
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 4,891		$ 4,891		$ 13,642

Financial Statement Component_6

Financial Statement Components - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Intangible Assets (Including Goodwill) [Roll Forward]
Beginning of the period			$ 22,077	$ 2,424	$ 2,424
Additions			8,240		21,890
Amortization expense	$ (1,100)	$ (700)	(3,258)	(1,500)	(2,237)
End of the period	27,059		27,059		22,077
Accumulated Amortization	$ (5,721)		$ (5,721)		$ (2,463)
Weighted Average Remaining Period (Years)	5 years 4 months 24 days		5 years 4 months 24 days		6 years 7 months 6 days
Amortization expense	$ 1,100	$ 700	$ 3,258	$ 1,500	$ 2,237
Indefinite-Lived Intangible Assets [Line Items]
IPR&D	7,500		7,500
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Gross Carrying Amount	32,780		32,780		24,540
Accumulated Amortization	(5,721)		(5,721)		(2,463)
Total	27,059		27,059		22,077
IPR&D
Indefinite-Lived Intangible Assets [Line Items]
IPR&D	7,500		7,500		7,500
Customer relationships
Intangible Assets (Including Goodwill) [Roll Forward]
Gross Carrying Amount	3,730		3,730		3,730
Accumulated Amortization	(1,275)		(1,275)		(664)
Net Carrying Amount	$ 2,455		$ 2,455		$ 3,066
Weighted Average Remaining Period (Years)	3 years 9 months 18 days		3 years 9 months 18 days		4 years 4 months 24 days
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	$ (1,275)		$ (1,275)		$ (664)
Customer backlog
Intangible Assets (Including Goodwill) [Roll Forward]
Gross Carrying Amount	650		650		650
Accumulated Amortization	(586)		(586)		(292)
Net Carrying Amount	$ 64		$ 64		$ 358
Weighted Average Remaining Period (Years)	2 months 12 days		2 months 12 days		10 months 24 days
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	$ (586)		$ (586)		$ (292)
Tradename
Intangible Assets (Including Goodwill) [Roll Forward]
Gross Carrying Amount	620		620		620
Accumulated Amortization	(307)		(307)		(214)
Net Carrying Amount	$ 313		$ 313		$ 406
Weighted Average Remaining Period (Years)	2 years 6 months		2 years 6 months		3 years 3 months 18 days
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	$ (307)		$ (307)		$ (214)
Assembled workforce
Intangible Assets (Including Goodwill) [Roll Forward]
Gross Carrying Amount	130		130		130
Accumulated Amortization	(130)		(130)		(130)
Net Carrying Amount	0		0		0
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	(130)		(130)		(130)
Developed technology
Intangible Assets (Including Goodwill) [Roll Forward]
Gross Carrying Amount	20,150		20,150		11,910
Accumulated Amortization	(3,423)		(3,423)		(1,163)
Net Carrying Amount	$ 16,727		$ 16,727		$ 10,747
Weighted Average Remaining Period (Years)	5 years 8 months 12 days		5 years 8 months 12 days		7 years 6 months
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	$ (3,423)		$ (3,423)		$ (1,163)

Financial Statement Component_7

Financial Statement Components - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
2023 (remaining three months)	$ 1,065
2024	4,001
2025	4,001
2026	3,354
2027	3,138
Thereafter	4,000
IPR&D	7,500
Total	$ 27,059	$ 22,077

Financial Statement Component_8

Financial Statement Components - Schedule of Goodwill (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Jun. 30, 2023	Sep. 30, 2023
Goodwill [Roll Forward]
Beginning balance		$ 18,816
Ending balance		19,879
Seagate
Goodwill [Roll Forward]
Goodwill related to acquisitions		1,063
Autonomy Solutions
Goodwill [Roll Forward]
Beginning balance		687
Ending balance		1,750
Autonomy Solutions \| Seagate
Goodwill [Roll Forward]
Goodwill related to acquisitions	$ 1,063	1,063
ATS
Goodwill [Roll Forward]
Beginning balance		18,129
Ending balance		18,129
ATS \| Seagate
Goodwill [Roll Forward]
Goodwill related to acquisitions		$ 0

Financial Statement Component_9

Financial Statement Components - Schedule of Other Noncurrent Assets (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Security deposits	$ 2,359	$ 5,495
Non-marketable equity investment (see Note 5 for additional information)	14,000	4,000
Advance payment for capital projects	0	27,683
Deferred tax assets	3,780	0
Contract assets	2,081	2,575
Other non-current assets	1,993	591
Other non-current assets	$ 24,213	$ 40,344

Financial Statement Componen_10

Financial Statement Components - Schedule of Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accrued compensation and benefits	$ 19,463		$ 19,463		$ 16,682
Accrued expenses	20,875		20,875		22,358
Contract losses	7,558		7,558		7,526
Warranty reserves	4,700		4,700		3,584
Contract liabilities	3,019		3,019		1,993
Accrued interest payable and other liabilities	2,874		2,874		819
Total accrued and other current liabilities	58,489		58,489		$ 52,962
Credit loss expense	$ 3,900	$ 6,100	$ 11,000	$ 10,600

Convertible Senior Notes and _3

Convertible Senior Notes and Capped Call Transactions - Narrative (Details)	1 Months Ended					9 Months Ended
	Dec. 31, 2021 USD ($) $ / shares	Dec. 31, 2021 USD ($) $ / shares	Dec. 31, 2021 USD ($) trading_day $ / shares	Dec. 31, 2021 USD ($) consecutive_trading_day $ / shares	Dec. 31, 2021 USD ($) consecutive_business_day $ / shares	Sep. 30, 2023 USD ($) $ / shares	Dec. 31, 2022 USD ($)
Debt Instrument [Line Items]
Stock option, capped calls, initial strike price (in dollars per share) \| $ / shares	$ 19.98	$ 19.98	$ 19.98	$ 19.98	$ 19.98
Stock option, capped calls, initial cap price (in dollars per share) \| $ / shares	$ 30.16	$ 30.16	$ 30.16	$ 30.16	$ 30.16
Class A Common Stock
Debt Instrument [Line Items]
Common stock, par value (in dollars per share) \| $ / shares						$ 0.0001
Convertible Senior Notes Due 2026 \| Convertible Debt
Debt Instrument [Line Items]
Principal \| $	$ 625,000,000	$ 625,000,000	$ 625,000,000	$ 625,000,000	$ 625,000,000	$ 625,000,000	$ 625,000,000
Interest rate (as a percent)	1.25%	1.25%	1.25%	1.25%	1.25%
Proceeds from the issuance of debt \| $		$ 75,000,000
Proceeds from convertible debt \| $		$ 609,400,000
Debt instrument, convertible, shares issuable (in shares)	0.0500475
Conversion price (in dollars per share) \| $ / shares	$ 19.98	$ 19.98	$ 19.98	$ 19.98	$ 19.98
Debt issuance costs, net \| $	$ 16,200,000	$ 16,200,000	$ 16,200,000	$ 16,200,000	$ 16,200,000
Note term (in months)						3 years 2 months 12 days
Payments to purchase capped calls \| $						$ 73,400,000
Convertible Senior Notes Due 2026 \| Convertible Debt \| Debt Instrument, Redemption, Period One
Debt Instrument [Line Items]
Debt instrument, convertible, threshold trading days \| trading_day			20
Debt instrument, convertible, threshold consecutive trading days \| consecutive_trading_day				30
Debt instrument, redemption price, percentage	100%
Convertible Senior Notes Due 2026 \| Convertible Debt \| Debt Instrument, Redemption, Period Two
Debt Instrument [Line Items]
Debt instrument, convertible, threshold percentage of stock price trigger	130%
Debt instrument, convertible, threshold trading days \| trading_day			20
Debt instrument, convertible, threshold consecutive trading days \| consecutive_trading_day				30
Convertible Senior Notes Due 2026 \| Convertible Debt \| Debt Instrument, Redemption, Period Three
Debt Instrument [Line Items]
Debt instrument, convertible, threshold trading days				10	5
Debt instrument, convertible, threshold percent of conversion price triggering convertible feature	98%
Convertible Senior Notes Due 2026 \| Convertible Debt \| Class A Common Stock
Debt Instrument [Line Items]
Common stock, par value (in dollars per share) \| $ / shares	$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001	$ 0.0001
Convertible Senior Notes Due 2026 \| Convertible Debt \| Class A Common Stock \| Debt Instrument, Redemption, Period One
Debt Instrument [Line Items]
Debt instrument, convertible, threshold percentage of stock price trigger	130%

Convertible Senior Notes and _4

Convertible Senior Notes and Capped Call Transactions - Schedule of Net Carrying Amount (Details) - Convertible Senior Notes Due 2026 - Convertible Debt - USD ($)	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Principal	$ 625,000,000	$ 625,000,000	$ 625,000,000
Unamortized debt discount and issuance costs	(10,381,000)	(12,808,000)
Net carrying amount	$ 614,619,000	$ 612,192,000

Convertible Senior Notes and _5

Convertible Senior Notes and Capped Call Transactions - Schedule of Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Debt Instrument [Line Items]
Total interest expense	$ 2,779	$ 2,660	$ 5,717	$ 9,088
Convertible Senior Notes Due 2026 \| Convertible Debt
Debt Instrument [Line Items]
Contractual interest expense	1,969	1,969	5,843	5,843
Amortization of debt discount and issuance costs	809	809	2,427	2,427
Total interest expense	$ 2,778	$ 2,778	$ 8,270	$ 8,270

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details)	Sep. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)
Level 3 \| Expected Term \| Private Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants term (in years)	2 years 2 months 4 days
Level 3 \| Price Volatility \| Private Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input (percent)	0.776
Level 3 \| Risk-Free Interest Rate \| Private Warrants
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants outstanding, measurement input (percent)	0.0499
Level 2
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible senior notes, fair value	$ 409,400,000	$ 352,500,000

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Changes in Level 3 Liabilities Measured at Fair Value (Details) - Warrants - Private Warrants $ in Thousands	9 Months Ended
	Sep. 30, 2023 USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning of period	$ 3,005
Change in fair value of outstanding warrants	(1,345)
Balance at end of period	$ 1,660

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of Financial Assets and Liabilities Subject to Fair Value Measurements on a Recurring Basis and the Level of Inputs Used (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Assets:
Marketable investments:	$ 243,003	$ 389,671
Liabilities:
Warrant liabilities	1,660	3,005
U.S. treasury securities
Assets:
Marketable investments:	205,792	188,480
U.S. agency and government sponsored securities
Assets:
Marketable investments:	5,691	4,924
Corporate bonds
Assets:
Marketable investments:	31,520	109,909
Asset-backed securities
Assets:
Marketable investments:		11,835
Fair Value, Recurring
Assets:
Total cash equivalents	33,932	42,056
Marketable equity investments	8,255	29,643
Total marketable investments	246,242	419,314
Fair Value, Recurring \| Private Warrants
Liabilities:
Warrant liabilities	1,660	3,005
Fair Value, Recurring \| U.S. treasury securities
Assets:
Marketable investments:	201,771	188,480
Fair Value, Recurring \| U.S. agency and government sponsored securities
Assets:
Marketable investments:	4,696	4,924
Fair Value, Recurring \| Commercial paper
Assets:
Marketable investments:		74,523
Fair Value, Recurring \| Corporate bonds
Assets:
Marketable investments:	31,520	109,909
Fair Value, Recurring \| Asset-backed securities
Assets:
Marketable investments:		11,835
Fair Value, Recurring \| Money market funds
Assets:
Total cash equivalents	28,916	42,056
Fair Value, Recurring \| U.S. treasury securities
Assets:
Total cash equivalents	4,021
Fair Value, Recurring \| U.S. agency and government sponsored securities
Assets:
Total cash equivalents	995
Level 1 \| Fair Value, Recurring
Assets:
Total cash equivalents	32,937	42,056
Marketable equity investments	8,255	29,643
Total marketable investments	210,026	218,123
Level 1 \| Fair Value, Recurring \| Private Warrants
Liabilities:
Warrant liabilities	0	0
Level 1 \| Fair Value, Recurring \| U.S. treasury securities
Assets:
Marketable investments:	201,771	188,480
Level 1 \| Fair Value, Recurring \| U.S. agency and government sponsored securities
Assets:
Marketable investments:	0	0
Level 1 \| Fair Value, Recurring \| Commercial paper
Assets:
Marketable investments:		0
Level 1 \| Fair Value, Recurring \| Corporate bonds
Assets:
Marketable investments:	0	0
Level 1 \| Fair Value, Recurring \| Asset-backed securities
Assets:
Marketable investments:		0
Level 1 \| Fair Value, Recurring \| Money market funds
Assets:
Total cash equivalents	28,916	42,056
Level 1 \| Fair Value, Recurring \| U.S. treasury securities
Assets:
Total cash equivalents	4,021
Level 1 \| Fair Value, Recurring \| U.S. agency and government sponsored securities
Assets:
Total cash equivalents	0
Level 2 \| Fair Value, Recurring
Assets:
Total cash equivalents	995	0
Marketable equity investments	0	0
Total marketable investments	36,216	201,191
Level 2 \| Fair Value, Recurring \| Private Warrants
Liabilities:
Warrant liabilities	0	0
Level 2 \| Fair Value, Recurring \| U.S. treasury securities
Assets:
Marketable investments:	0	0
Level 2 \| Fair Value, Recurring \| U.S. agency and government sponsored securities
Assets:
Marketable investments:	4,696	4,924
Level 2 \| Fair Value, Recurring \| Commercial paper
Assets:
Marketable investments:		74,523
Level 2 \| Fair Value, Recurring \| Corporate bonds
Assets:
Marketable investments:	31,520	109,909
Level 2 \| Fair Value, Recurring \| Asset-backed securities
Assets:
Marketable investments:		11,835
Level 2 \| Fair Value, Recurring \| Money market funds
Assets:
Total cash equivalents	0	0
Level 2 \| Fair Value, Recurring \| U.S. treasury securities
Assets:
Total cash equivalents	0
Level 2 \| Fair Value, Recurring \| U.S. agency and government sponsored securities
Assets:
Total cash equivalents	995
Level 3 \| Fair Value, Recurring
Assets:
Total cash equivalents	0	0
Marketable equity investments	0	0
Total marketable investments	0	0
Level 3 \| Fair Value, Recurring \| Private Warrants
Liabilities:
Warrant liabilities	1,660	3,005
Level 3 \| Fair Value, Recurring \| U.S. treasury securities
Assets:
Marketable investments:	0	0
Level 3 \| Fair Value, Recurring \| U.S. agency and government sponsored securities
Assets:
Marketable investments:	0	0
Level 3 \| Fair Value, Recurring \| Commercial paper
Assets:
Marketable investments:		0
Level 3 \| Fair Value, Recurring \| Corporate bonds
Assets:
Marketable investments:	0	0
Level 3 \| Fair Value, Recurring \| Asset-backed securities
Assets:
Marketable investments:		0
Level 3 \| Fair Value, Recurring \| Money market funds
Assets:
Total cash equivalents	0	$ 0
Level 3 \| Fair Value, Recurring \| U.S. treasury securities
Assets:
Total cash equivalents	0
Level 3 \| Fair Value, Recurring \| U.S. agency and government sponsored securities
Assets:
Total cash equivalents	$ 0

Earnings (Loss) Per Share - Sch

Earnings (Loss) Per Share - Schedule of Basic and Diluted Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Numerator:
Net loss	$ (134,338)	$ (117,550)	$ (422,868)	$ (301,122)
Denominator:
Weighted average common shares outstanding- Basic (in shares)	394,591,942	359,753,254	382,673,871	353,537,754
Weighted average common shares outstanding- Diluted (in shares)	394,591,942	359,753,254	382,673,871	353,537,754
Net loss per share - Basic (in dollars per share)	$ (0.34)	$ (0.33)	$ (1.11)	$ (0.85)
Net loss per share - Diluted (in dollars per share)	$ (0.34)	$ (0.33)	$ (1.11)	$ (0.85)

Earnings (Loss) Per Share - S_2

Earnings (Loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)	9 Months Ended
	Sep. 30, 2023 shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	95,359,219
Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	5,757,549
Stock-based awards—Equity classified
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	36,794,743
Stock-based awards—Liability classified
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	12,355,018
Vendor stock-in-lieu of cash program
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	565,476
Convertible Senior Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	31,279,716
Earn-out shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total (in shares)	8,606,717

Earnings (Loss) Per Share - Nar

Earnings (Loss) Per Share - Narrative (Details)	Sep. 30, 2023 $ / shares
Convertible Senior Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Conversion price (in dollars per share)	$ 19.981

Stockholders' Equity - Narrativ

Stockholders' Equity - Narrative (Details) $ / shares in Units, $ in Thousands					3 Months Ended		9 Months Ended
	May 15, 2023 USD ($) shares	May 09, 2023 USD ($) shares	May 08, 2023 USD ($) shares	Feb. 28, 2023 USD ($)	Sep. 30, 2023 USD ($) classOfStock vote $ / shares shares	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($) classOfStock vote $ / shares shares	Sep. 30, 2022 USD ($)	Dec. 31, 2022 shares
Class of Stock [Line Items]
Number of classes of stock \| classOfStock					2		2
Sale of stock, gross proceeds \| $					$ 904	$ 1,102	$ 2,553	$ 2,846
Vendor payments in shares in lieu of cash (in shares)							6,505,012
Vendor payments in stock in lieu of cash, liability \| $					$ 6,100		$ 6,100
Pony. AI, Inc
Class of Stock [Line Items]
Vendor payments in shares in lieu of cash (in shares)							1,564,822
Private Warrants
Class of Stock [Line Items]
Warrants outstanding (in shares)									1,668,269
Warrants exercised (in shares)					0		0
Share per warrant (in shares)					1		1
Stock price of warrants (in dollars per share) \| $ / shares					$ 11.50		$ 11.50
Equity Financing Program
Class of Stock [Line Items]
Stock issuance sales agreement, authorized offering amount \| $				$ 75,000
Sale of stock, gross proceeds \| $					$ 9,107		$ 38,711
Class A Common Stock
Class of Stock [Line Items]
Common stock, shares authorized (in shares)					715,000,000		715,000,000
Common stock, par value (in dollars per share) \| $ / shares					$ 0.0001		$ 0.0001
Common stock, shares issued (in shares)					325,908,478		325,908,478
Common stock, shares outstanding (in shares)					304,045,028		304,045,028
Common stock, votes per share \| vote					1		1
Sale of stock, shares issued in transaction	1,652,892		1,652,892
Sale of stock, gross proceeds \| $	$ 10,000		$ 10,000
Granted (in shares)		1,652,892
Option to purchase additional shares granted amount \| $		$ 10,000
Class A Common Stock \| Equity Financing Program
Class of Stock [Line Items]
Sale of stock (in shares)					1,833,829		5,599,121
Sale of stock, gross proceeds \| $					$ 9,100		$ 38,700
Common stock available for future issuance \| $					$ 35,900		$ 35,900
Class B Common Stock
Class of Stock [Line Items]
Common stock, shares authorized (in shares)					121,000,000		121,000,000
Common stock, par value (in dollars per share) \| $ / shares					$ 0.0001		$ 0.0001
Common stock, shares issued (in shares)					97,088,670		97,088,670
Common stock, shares outstanding (in shares)					97,088,670		97,088,670
Common stock, votes per share \| vote					10		10

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of Vendor Stock-in-lieu of Cash Program (Details) - Vendor stock-in-lieu of cash program	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Shares
Outstanding at beginning of period (in shares) \| shares	1,047,151
Granted (in shares) \| shares	6,505,012
Vested (in shares) \| shares	(6,038,523)
Outstanding at end of period (in shares) \| shares	1,513,640
Weighted Average Grant Date Fair Value per Share
Outstanding at beginning of period (in dollars per share) \| $ / shares	$ 11.90
Granted (in dollars per share) \| $ / shares	6.13
Vested (in dollars per share) \| $ / shares	6.55
Outstanding at end of period (in dollars per share) \| $ / shares	$ 8.45

Stock-based Compensation - Narr

Stock-based Compensation - Narrative (Details) $ / shares in Units, $ in Thousands

1 Months Ended

3 Months Ended

6 Months Ended

9 Months Ended

48 Months Ended

Mar. 16, 2023 USD ($) trading_day tranche $ / shares

Jan. 01, 2023 shares

Aug. 19, 2022 $ / shares shares

May 02, 2022 $ / shares shares

Aug. 31, 2023 shares

May 31, 2023 USD ($) shares

Aug. 31, 2022 USD ($) shares

Jun. 30, 2022 shares

Apr. 30, 2022 USD ($)

Aug. 31, 2021 USD ($)

Sep. 30, 2023 USD ($)

Sep. 30, 2022 USD ($)

Jun. 30, 2019

Sep. 30, 2023 USD ($) trading_day $ / shares shares

Sep. 30, 2022 USD ($)

Jun. 30, 2023 shares

Dec. 31, 2020 shares

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Intrinsic value of stock options exercised | $

$ 7,400

Fair value of options vested | $

$ 1,600

Shares issued upon vesting of each RSU

Stock-based compensation expense | $

$ 44,882

$ 52,551

$ 160,031

$ 117,874

Optogration Milestone Awards

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Contingent stock consideration | $

$ 22,000

Freedom Photonics Awards

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Contingent stock consideration | $

$ 29,800

20,900

Class A Common Stock | Optogration Milestone Awards

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based arrangement awards (in shares) | shares

1,527,788

1,632,056

Share-based arrangement awards | $

$ 11,000

Share-based arrangement awards, remaining obligations | $

11,000

$ 11,000

Class A Common Stock | Freedom Photonics Awards

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based arrangement awards (in shares) | shares

634,994

Share-based arrangement awards | $

$ 3,900

Stock-based awards—Liability classified | Share-based Payment Arrangement, Employee

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years and in months)

4 years

Granted (in shares) | shares

Stock-based awards—Liability classified | Tranche One | Share-based Payment Arrangement, Employee

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting percentage

25%

Stock-based awards—Liability classified | Tranche Two | Share-based Payment Arrangement, Employee

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years and in months)

36 months

Award vesting percentage

75%

RSUs

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in shares) | shares

19,351,770

RSUs | Freedom Photonics Awards

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Share-based arrangement awards (in shares) | shares

492,176

Share-based arrangement awards | $

$ 3,500

RSUs | Maximum

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years and in months)

6 years

Management awards

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in shares) | shares

370,000

Management awards | Chief Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in shares) | shares

10,800,000

Grant date fair value (in dollars per share) | $ / shares

$ 8.70

Management awards | Chief Legal officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in shares) | shares

500,000

Grant date fair value (in dollars per share) | $ / shares

$ 6.12

Management awards | Chief Financial Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in shares) | shares

500,000

Grant date fair value (in dollars per share) | $ / shares

$ 6.12

Management awards | Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Stock-based compensation expense | $

5,600

$ 16,900

Grant date fair value (in dollars per share) | $ / shares

$ 8.58

Consecutive trading days | trading_day

Service period (in years)

7 years

Granted | $

$ 12,000

Fair value of restricted stock vested | $

$ 2,000

Number of tranches | tranche

Trading days | trading_day

Management awards | Tranche One | Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

RSU vesting, market condition, stock price (in dollars per share) | $ / shares

$ 20

Management awards | Tranche Two | Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

RSU vesting, market condition, stock price (in dollars per share) | $ / shares

Management awards | Tranche Three | Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

RSU vesting, market condition, stock price (in dollars per share) | $ / shares

Management awards | Tranche Four | Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

RSU vesting, market condition, stock price (in dollars per share) | $ / shares

Management awards | Tranche Five | Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

RSU vesting, market condition, stock price (in dollars per share) | $ / shares

Management awards | Tranche Six | Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

RSU vesting, market condition, stock price (in dollars per share) | $ / shares

$ 60

Management awards | Achievement of stock price one | Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

RSU vesting, market condition, stock price (in dollars per share) | $ / shares

$ 50

Management awards | Achievement of stock price two | Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

RSU vesting, market condition, stock price (in dollars per share) | $ / shares

Management awards | Achievement of stock price three | Executive Officer

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

RSU vesting, market condition, stock price (in dollars per share) | $ / shares

$ 70

2020 Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Shares authorized for issuance (in shares) | shares

36,588,278

2020 Plan | Equity-settled fixed value | Share-based Payment Arrangement, Employee

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years and in months)

4 years

Stock-based compensation expense | $

$ 4,200

$ 1,900

$ 10,100

$ 5,400

Amended 2020 Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Additional shares authorized for issuance (in shares) | shares

36,000,000

Percentage of outstanding stock maximum

Incremental number of shares authorized (in shares) | shares

40,000,000

Amended 2020 Plan | Class A Common Stock

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Additional shares authorized for issuance (in shares) | shares

18,358,365

2015 Plan | Stock-based awards—Equity classified

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years and in months)

4 years

Award expiration period (in years)

10 years

2015 Plan | Stock-based awards—Equity classified | Tranche One

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting percentage

25%

2015 Plan | Stock-based awards—Equity classified | Tranche Two

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Award vesting period (in years and in months)

36 months

Award vesting percentage

75%

Stock-based Compensation - Sche

Stock-based Compensation - Schedule of Stock Option Activity (Details) $ / shares in Units, $ in Thousands	9 Months Ended
	Sep. 30, 2023 USD ($) $ / shares shares
Number of Common Stock Options
Outstanding at beginning of period (in shares) \| shares	8,162,850
Exercised (in shares) \| shares	(1,528,472)
Cancelled/Forfeited (in shares) \| shares	(125,909)
Outstanding at end of period (in shares) \| shares	6,508,469
Weighted- Average Exercise Price
Outstanding at beginning of period (in dollars per share) \| $ / shares	$ 1.74
Exercised (in dollars per share) \| $ / shares	1.67
Cancelled/Forfeited (in dollars per share) \| $ / shares	1.67
Outstanding at end of period (in dollars per share) \| $ / shares	$ 1.76
Weighted- Average Remaining Contractual Life (Years)
Outstanding balance	6 years 3 months 29 days
Aggregate Intrinsic Value (In Thousands)
Outstanding balance \| $	$ 18,342

Stock-based Compensation - Sc_2

Stock-based Compensation - Schedule of Restricted Stock Awards Activity (Details)	9 Months Ended
	Sep. 30, 2023 $ / shares shares
Stock-based awards—Liability classified
Shares
Outstanding at beginning of period (in shares) \| shares	64,486
Vested (in shares) \| shares	(64,486)
Outstanding at end of period (in shares) \| shares	0
Weighted Average Grant Date Fair Value per Share
Outstanding at beginning of period (in dollars per share) \| $ / shares	$ 1.29
Vested (in dollars per share) \| $ / shares	1.29
Outstanding at end of period (in dollars per share) \| $ / shares	$ 0
RSUs
Shares
Outstanding at beginning of period (in shares) \| shares	25,010,688
Granted (in shares) \| shares	19,351,770
Forfeited (in shares) \| shares	(3,038,849)
Vested (in shares) \| shares	(11,376,691)
Change in units based on performance (in shares) \| shares	0
Outstanding at end of period (in shares) \| shares	29,946,918
Weighted Average Grant Date Fair Value per Share
Outstanding at beginning of period (in dollars per share) \| $ / shares	$ 12.76
Granted (in dollars per share) \| $ / shares	6.75
Forfeited (in dollars per share) \| $ / shares	11.07
Vested (in dollars per share) \| $ / shares	11.01
Change in units based on performance (in dollars per share) \| $ / shares	0
Outstanding at end of period (in dollars per share) \| $ / shares	$ 9.71
Performance-Based and Other RSUs
Shares
Outstanding at beginning of period (in shares) \| shares	583,347
Granted (in shares) \| shares	961,187
Forfeited (in shares) \| shares	(750,301)
Vested (in shares) \| shares	(284,046)
Change in units based on performance (in shares) \| shares	(206,785)
Outstanding at end of period (in shares) \| shares	303,402
Weighted Average Grant Date Fair Value per Share
Outstanding at beginning of period (in dollars per share) \| $ / shares	$ 8.39
Granted (in dollars per share) \| $ / shares	8.58
Forfeited (in dollars per share) \| $ / shares	8.15
Vested (in dollars per share) \| $ / shares	7.45
Change in units based on performance (in dollars per share) \| $ / shares	9.65
Outstanding at end of period (in dollars per share) \| $ / shares	$ 9.60
Management awards
Shares
Outstanding at beginning of period (in shares) \| shares	11,800,000
Granted (in shares) \| shares	370,000
Forfeited (in shares) \| shares	(370,000)
Outstanding at end of period (in shares) \| shares	11,800,000
Weighted Average Grant Date Fair Value per Share
Outstanding at beginning of period (in dollars per share) \| $ / shares	$ 8.48
Granted (in dollars per share) \| $ / shares	6.80
Forfeited (in dollars per share) \| $ / shares	6.80
Outstanding at end of period (in dollars per share) \| $ / shares	$ 8.48

Stock-based Compensation - Sc_3

Stock-based Compensation - Schedule of Stock-based Compensation Expense by Function (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 44,882	$ 52,551	$ 160,031	$ 117,874
Equity-settled fixed value
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	4,150	1,894	10,066	5,013
Optogration
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	495	5,312	6,154	8,759
Freedom Photonics
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	687	3,155	10,219	5,955
Other
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	(496)	1,569	6,939	2,029
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	491	714	1,752	1,984
RSAs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	0	162	61	183
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	33,593	33,930	106,631	84,484
Management awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	5,560	5,522	17,059	9,017
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	402	293	1,150	450
Cost of sales
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	2,255	5,430	6,842	14,205
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	12,886	11,326	50,898	27,142
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	6,536	3,821	22,156	9,430
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense	$ 23,205	$ 31,974	$ 80,135	$ 67,097

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details)	9 Months Ended
Income Taxes - Narrative (Details)	Sep. 30, 2023	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Effective tax rate, percent	0.10%	0.20%

Leases - Narrative (Details)

Leases - Narrative (Details)	9 Months Ended
Leases - Narrative (Details)	Sep. 30, 2023 USD ($) renewal_option
Lessee, Lease, Description [Line Items]
Short-term leases	$ 0
Sublease income	$ 0
Minimum
Lessee, Lease, Description [Line Items]
Number of renewal options \| renewal_option	1
Renewal lease term (in years)	1 year
Maximum
Lessee, Lease, Description [Line Items]
Renewal lease term (in years)	6 years

Leases - Schedule of Components

Leases - Schedule of Components of Lease Expenses (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Leases [Abstract]
Operating lease cost	$ 2,111	$ 1,722	$ 6,111	$ 4,435
Variable lease cost	494	546	1,528	1,616
Total operating lease cost	$ 2,605	$ 2,268	$ 7,639	$ 6,051

Leases - Schedule of Supplement

Leases - Schedule of Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash paid for amounts included in the measurement of lease liabilities:
Cash paid for operating leases included in operating activities	$ (5,358)	$ (4,430)
Right of use assets obtained in exchange for lease obligations:
Operating leases	$ 3,335	$ 16,749

Leases - Schedule of Suppleme_2

Leases - Schedule of Supplemental Balance Sheet Information, Weighted Average Remaining Terms, and Weighted Average Discount Rates (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Operating leases:
Operating lease right-of-use assets	$ 19,660	$ 21,244
Operating lease liabilities, current	6,475	5,953
Operating lease liabilities, non-current	15,551	16,989
Total operating lease liabilities	$ 22,026	$ 22,942
Weighted average remaining lease term
Operating leases (in years)	4 years 3 days	4 years 5 months 4 days
Weighted average discount rate
Operating leases (as a percent)	5.97%	5.45%

Leases - Schedule of Maturities

Leases - Schedule of Maturities of Lease Liabilities (Details) - USD ($) $ in Thousands	Sep. 30, 2023	Dec. 31, 2022
Operating Leases
2023 (remaining three months)	$ 1,951
2024	6,123
2025	5,789
2026	5,310
2027	4,208
2028	1,363
Total lease payments	24,744
Less: imputed interest	(2,718)
Total leases liabilities	$ 22,026	$ 22,942

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Millions	Sep. 30, 2023 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Purchase obligation	$ 104.1

Segment and Customer Concentr_3

Segment and Customer Concentration Information - Schedule of Segment Operating Results and Reconciliation to the Consolidated Balances (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Revenue:
Revenue	$ 16,959	$ 12,785	$ 47,665	$ 29,572
Depreciation and amortization	11,932	1,830	19,468	4,374
Operating income (loss)	(128,929)	(114,954)	(414,716)	(301,725)
Other significant items:
Segment assets	552,878	742,508	552,878	742,508	$ 687,327
Inventories, net	16,698	9,153	16,698	9,153	$ 8,792
Reportable Segments
Revenue:
Depreciation and amortization	11,932	1,830	19,468	4,374
Operating income (loss)	(131,270)	(114,733)	(415,951)	(301,504)
Other significant items:
Segment assets	756,111	818,241	756,111	818,241
Inventories, net	16,735	9,374	16,735	9,374
Eliminations
Revenue:
Depreciation and amortization	0	0	0	0
Operating income (loss)	2,341	(221)	1,235	(221)
Other significant items:
Segment assets	(203,233)	(75,733)	(203,233)	(75,733)
Inventories, net	(37)	(221)	(37)	(221)
Autonomy Solutions
Revenue:
Revenue	11,229	6,777	31,640	16,854
Autonomy Solutions \| Reportable Segments
Revenue:
Depreciation and amortization	11,231	1,176	17,423	2,696
Operating income (loss)	(131,943)	(116,601)	(393,794)	(304,370)
Other significant items:
Segment assets	676,874	765,241	676,874	765,241
Inventories, net	15,800	8,838	15,800	8,838
ATS
Revenue:
Revenue	5,730	6,008	16,025	12,718
ATS \| Reportable Segments
Revenue:
Depreciation and amortization	701	654	2,045	1,678
Operating income (loss)	673	1,868	(22,157)	2,866
Other significant items:
Segment assets	79,237	53,000	79,237	53,000
Inventories, net	$ 935	$ 536	$ 935	$ 536

Segment and Customer Concentr_4

Segment and Customer Concentration Information - Narrative (Details) - Revenue from contract with customer benchmark - Customer Concentration Risk	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Customer A
Concentration Risk [Line Items]
Percentage of revenue (as percent)	32%	30%	30%	13%
Customer B
Concentration Risk [Line Items]
Percentage of revenue (as percent)	14%	12%	16%	25%
Customer C
Concentration Risk [Line Items]
Percentage of revenue (as percent)	14%